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SUMMARY 
Nitroglycerin aind 	isosorbide dinitrate are two drugs which 
are infused intravenously during the treatment of ischaemic 
heart disease. 	The availability of these two drugs in 
solutions infused 	from plastic 	infusion bags or glass 
infusion bottles through plastic giving 	sets has been 
investigated. 
During simulated infusions the concentration of nitroglycerin 
and 	isosorbide dinitrate appearing in the effluent of the 
• 
giving set tubing was found to be much less than the 
concentration of the drug solution initially contained in the 
plastic infusion bag or glass infusion bottle. It was found 
that each component of the plastic infusion equipment sorbed 
the drugs to a significant extent and that the rate of 
disappearance of drugs from solutions stored in each 
component was in the rank order: 	giving set tubing > giving 
set burette > plastic infusion bag. 	There was no significant 
loss of either drug from solutions stored 	in glass bottles. 
The influence of formulation factors and storage conditions 
on the sorption of nitroglycerin, isosorbide dinitrate and 
another organic nitrate compound., ethylene glycol dinitrate, 
by plastic infusion equipment was studied. The extent of 
loss during simulated infusions was also found to be 
dependent on flow rate of drug solution through the giving 
set. 
The sorption of nitroglycerin and isosorbide dinitrate has 
clinical and pharmacokinetic significance. 
Losses of nitroglycerin and isosorbide dinitrate associated 
with their infusion through plastic Lnfusion equipment were 
minimised by infusing drug solutions from a glass syringe 
through high density polyethylene tubing. This method was 
also successfully applied to overcome the previously reported 
loss of diazepam and chlormethiazole during infusions using 
conventional plastic administration equipment. 
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CHAPTER 1 
INTRODUCTION 
1.1. INTRAVENOUS ADMINISTRATION OF ORGANIC NITRATES 
Intravenous (I.V.) medication is administered directly into 
a vein either to provide an initial rapid response which 
may be maintained with further infusion of drug, or to 
overcome the variations in bioavailability associated with 
other routes of administration. This route of 
administration ensures maximum bioavailability. The 
duration of drug activity is dependent on the initial dose 
and the pharmacokinetics of the drug. Drugs with short 
half—lives and for which constant and sustained drug 
amounts are required, are often administered as a 
continuous I.V. infusion (Boylan 	and 	Fites, 1979; 	Niazi, 
1979). 	The 	extent and rate of drug delivery with 	I.V. 
infusions are generally 	better controlled than other 
methods used to obtain sustained drug action. 
A number of studies have shown that the organic nitrates 
can be administered intravenously for specific therapeutic 
applications. From experiments in dogs Epstein et al 
(1975) found that when nitroglycerin (GIN) was administered 
intravenously as a 400mcg bolls followed by a continuous 
infusion of 300 mcg/min, coronary occlusion produced much 
less ischaemic injury than it did in dogs not previously 
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treated with nitroglycerin. 	These workers concluded that 
it is possible that the administration of nitroglycerin to 
patients 	suffering 	acute 	myocardial 	infarction, 
• irrespective of the presence of left ventricular failure, 
would reduce the frequency and severity of transmural 
infarction and so enhance the prospects of long term 
survival. 
Chiche et al 	(1979) 	showed that prolonged nitroglycerin 
infusion resulted in less progression of 
electrocardiographic parameters of ischaemia and necrosis 
in patients suffering acute myocardial infarction. 
Intravenous infusions of isosorbide dinitrate 	(ISDN) 	have 
been used successfully for the treatment of severe angina 
(Distante et al, 1979). 
In late 1977 	some patients admitted to the Royal Hobart 
Hospital suffering acute myocardial infarction failed to 
respond adequately to nitroglycerin given by intravenous 
infusion. Little haemodynamic response was observed except 
at the initial infusion rate, despite a continual increase 
of nitroglycerin infusion rate (to a final 	intended value 
of 300' mcg/min). 	Two possibilities were suggested to 
explain the poor response of those patients; 	either 
nitroglycerin was not being delivered to the patients in 
sufficient quantity due to interaction with the delivery 
system, or the patients failed to respond to the drug as a 
result of some pharmacodynamic/pharmacokinetic 	factor. 
This present work reports the studies resulting from 
investigation of the former possibility. 
1.2. DEVELOPMENT OF PLASTIC DELIVERY SYSTEMS 
,1.2.1. Intravenous Infusion Bags. 
The polyvinyl chloride intravenous fluid bag (Viaflex) was 
introduced by Travenol Laboratories in 1971. These bags 
have some advantages over glass infusion bottles and are 
therefore preferable for certain therapeutic indications. 
Because plastic infusion bags collapse on emptying, the 
need to replace an equivalent volume of air is overcome and 
so the risk of contamination from air-borne microbes is 
greatly reduced, as is the risk of embolism. Furthermore, 
extra medication can be added by syringe to the plastic 
infusion bag without the risk of air entering the bag. In 
order to pressure-infuse solutions, the soft bag can be 
squeezed. Other lesser points of advantage include the bag 
being easy to support in the correct position, its 
resistance to breakage and the ease of disposal of used 
bags. 
Petrick et al (1977) have reviewed the problems associated 
with the use of plastic intravenous bags. The major 
problems which arise in using these bags include human 
touch contamination, the generation of particulate matter, 
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the potential 	to insufficiently mix I.V. 	additives when 
injected into plastic 	I.V. 	bags, 	the 	leaching of toxic 
stabilizers and/or plasticizers from the plastic into• the 
I.V. solution and sorption of drugs from solution by the 
plastic I.V. bag. 	Petrick et al (1977) concluded that only 
a financial consideration made 	the use of the plastic I.V. 
bag more advantageous than the glass bottle. 
1.2.2. Intravenous Infusion Giving Sets 
The method of administration of intravenous fluids had for 
many years been through plastic tubing with only a crude 
means of controlling 	the flow rate. 	In the early 1970's 
several companies released a plastic volume control 	set 
which 	offers 	several distinct advantages over those 
administration sets previously used. 	The in—line burette, 
made of cellulose propionate, 	allows accurate measurement 
of fluid intake and at the same time limits the volume of 
fluid which may be accidentally infused. 	The burette 
chamber also offers the provision of intermittent 
intravenous therapy with different drugs, and a membrane 
filter at the base of the burette prevents any air or 
microbial contaminants being infused into the patient. 
Henry and Harrison (1972) discussed 	a number of potential 
errors which could occur with the use of plastic volume 
control giving sets. 	These ranged from accidental flooding 
of large volumes of intravenous fluid, to the admixture of 
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two or more incompatible drugs in the burette. Duma et al 
(1971) found that the intravenous giving set was frequently 
a starting point for bacterial infections in the patient 
being infused and the contamination arose from the hands of 
personnel •changing the giving set during the introduction 
of additives. Henry and Harrison (1972) concluded that 
contamination is compounded each time medication addition 
ports are used. These ports, . invariably set upright, can 
become gathering points for dust and other contamination 
and can lead to infection unless regularly cleaned before 
use. Contamination of volume control sets by Bacillus 
subtilus, 	Staphylococcus epidermidis and 	Aspergillus slop 
was reported by McAllister et al (1974). 
The variation in drip rate within gravity-fed plastic 
giving sets can result in a very large fluctuation in 
volume being delivered to a patient (Flack and Whyte, 
1974). This has been shown to be almost completely due to 
variation in the patient's venous pressure which changes 
dramatically with posture. Flack and Whyte (1974) 
recommended that to obtain a relatively constant flow rate, 
gravity-fed giving sets should be provided with a 
servo-control mechanism-. 
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1.3. ORGANIC NITRATES 
1.3.1. Pharmacology 
Although nitroglycerin and isosorbide dinitrate are the 
most widely used organic nitrates, the pharmacology of 
erythritol tetranitrate, pentaerythritol tetranitrate and 
mannitol hexanitrate has also been evaluated (Krantz et al, 
1939a; Carr, 1975). 
The basic pharmacological action of the organic nitrates is 
to relax smooth muscle resulting in an increase in venous 
capacitance. In this way elevated ventricular filling 
pressure, central venous pressure and end-diastolic volume 
are reduced and the overall result can be a reduction in 
the myocardial oxygen demand (Brachfeld et al, 1959; Rowe 
et al, 1961; Parratt, 1980). Nitroglycerin has also been 
shown to dilate arteriosclerotic coronary vessels (Parratt, 
1980). Through their effects on smooth muscle, organic 
nitrates also reduce pulmonary oedema and have been used to 
treat biliary colic. 
Nitroglycerin has been shown to possess moderate positive 
inotropic 	activity 	(Parratt, 	1979) 	and 	to decrease the 
susceptibility to ventricular 	fibrillation during acute 
myocardial ischaemia (Stockman et al, 1979). 
6 
Reviews of the pharmacological action of organic nitrates 
on smooth muscle have been presented by Carr (1975), 
Needleman and Johnson (1975) and Parratt (1980). 
Nitroglycerin and isosorbide dinitrate have also been shown 
to be inhibitors of platelet function (Schafer et al, 
1980). 
1.3.2. Therapeutics 
Continuous intravenous infusions of nitroglycerin have been 
used in the therapy of acute 	myocardial 	infarction 
(Flaherty et al, 1975; 	Armstrong et al, 1975; Come 	et al, 
1975). 	It 	is suggested 	that nitroglycerin 	reduces 
ischaemic injury to the myocardium when administered 
immediately after the onset of a myocardial infarction, 
thus limiting infarct size. Nitroglycerin infusions are 
also used to decrease cardiac pre- and after-loads in 
patients undergoing coronary artery bypass surgery (Kaplan 
et al, 1976; Glisson et al, 1980). 
Distante 	et al 	(1979) 	have shown that a continuous 
intravenous infusion of isosorbide dinitrate is an 
effective treatment for patients with vasospastic angina at 
rest. 
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CHAPTER 2 
AVAILABILITY OF DRUGS FROM PARENTERAL SOLUTIONS 
2.1. DRUG-DELIVERY SYSTEM INTERACTIONS 
2.1.1. Types of Interactions 
Drugs and other additives in parenteral solutions may 
interact with delivery systems in numerous ways. 
(a) Adsorption 
Adsorption describes the interaction at the interface of a 
drug solution-delivery system. Adsorption occurs in both 
glass and plastic containers and results in a reduction of 
the drug concentration in the infusion solution. 
(b) Absorption 
The partitioning and diffusion of a drug into the matrix of 
a membrane or container wall is referred to as absorption. 
This process does not readily occur in glass containers. 
Adsorption and absorption together comprise the process of 
sorption. 	The partition coefficient of a solute between 
its aqueous solutions and a plastic system is the major 
• factor determining whether sorption will occur (Jordan and 
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Polack, 1972) and this may be dependent upon the pH of the 
solution and the nature of the solvent 'system. 
Temperature, the concentration of solute and ionic strength 
of the solution are other' factors which may increase or 
decrease the magnitude of sorption (Autian, 1971). 
(c) Permeation 
Permeation is the movement of solute molecules from the 
environment on one side of a membrane to the environment on 
the other side. Sorption is often an essential 
prerequisite for permeation since permeation usually cannot 
occur unless the solute has been sorbed by the plastic. 
The nature of the penetrant molecule as well as the 
properties of the plastic material are the major factors 
influencing the rate of transfer of molecules from one side 
of a plastic membrane to the other side. Temperature, pH, 
nature of the solvent, the concentration of the solute and 
the ionic strength of the solution all influence the 
sorption and permeation of molecules from their aqueous 
solution into/through a plastic sheet (F.D.A : notes, 
1974/75). 
(d) Leaching 
Leaching refers to the migration of an ingredient of a 
plastic or glass material into a solution 	in 	contact - with 
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the container. 	Compounds leached from plastic containers 
are generally plasticizers, stabilizers or antioxidants. 
Leaching of silica, alumina and alkali can occur from glass 
(Autian, 1971). 
Leaching 	is influenced by the solubility of leached 
material in solution, 	temperature, excessive agitation of 
the filled container, pH and 	time of contact of solution 
with container (Autian, 1971). 
(e) Chemical Reactivity 
The interaction of a polymer or one of the additives in the 
polymer with a drug can occur. 	Very rarely does the 
chemical reaction of a diffusing molecule occur with the 
polymer itself. 	More often it occurs with an antioxidant 
in the plastic. 	Staining or discolouration of a plastic is 
the most common result of the chemical reaction of a 
parenteral additive and a plastic (Autian, 1971). 
(f) Alterations in the Properties of a Container 
Sorption, permeation, leaching and chemical reactivity may 
all result in the physical condition of a plastic container 
being changed. 	A sorbed ingredient may act as a 
plasticizing agent and 	permit 	greater polymer chain 
flexibility which increases the permeation 	of sorbed 
molecules 	or 	gases 	through the plastic. 	When an 
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antioxidant is leached from a plastic, oxidation of the 
polymer chains occurs with subsequent degradation of the 
polymer (Autian, 1971). 
Degradation of some types of polymers can also occur under 
the influence of heat and ultraviolet light. 
2.1.2. Models of Drug Sorption Interactions 
(a) Partition Coefficient and the Two Compartment Model 
In considering the sorption of a drug from its aqueous 
solution by a 	plastic, 	the partition coefficient 	is 
expressed in terms of the ratio of the equilibrium 
concentration of the drug in the non-aqueous phase to the 
concentration in the aqueous phase. The plastic-water 
partition coefficient may be viewed as an index of the 
relative affinity of the drug for a plastic and the vehicle 
in which the drug is dissolved. 
The partitioning of a drug between the aqueous phase and a 
plastic, such as polyvinyl chloride or polyethylene, may be 
considered analagous to the partitioning of a solute 
between water and oil. Moreover, aliphatic hydrocarbons 
can be considered to have similar partitioning 
characteristics to polyvinyl chloride and polyethylene 
because like those two plastics, aliphatic hydrocarbons 
such as (n-)hexane 	and 	(n-)octanol have free -CH2 - 
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Figure 2.1 Unit structures of some polymers used in 
medical applications. 
functional groups (Figure 2.1) 
Polack et al (1970) related the loss of a number of solutes 
from polyethylene containers to the hexane-water partition 
coefficient of the solute. Further work by Jordan and 
Polack (1972) and Robert's et al (1979) confirmed that the 
rate of permeation of a solute through polyethylene films 
may be correlated with the hexane-water partition 
coefficient of the solute. 
From a study of eleven binary systems, Smith et al (1975) 
suggested that the octanol-water system is the best 
reference system for biological partitioning and activity 
in drug design work. It is possible that octanol-water 
partition coefficients may also be used to predict the 
extent of uptake of drugs by polymer films. Octanol-water 
partition coefficients have been correlated by Kowaluk et 
al (1981) and Krieglstein et al (1972) with the extent of 
sorption of a series of phenothiazines 	by polyvinyl 
chloride. 
The disappearance kinetics of some solutes from solutions 
stored 	in plastic containers has been desci-ibed by a two 
compartment open model 	(Roberts et al, 1979; Polack et al, 
1979) (Figure 2.2). 
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Figure 2.2 Two compartment model used to examine disappearance kinetics of solutes 
from aqueous solutions stored in plastic containers. 'F' and 'V' refer 
to the fraction of solute remaining in, and the volume of, each of the 
compartments 'S' and 'W', the solution and container wall respectively. 
(See text for details). 
This model describes the uptake of solute from its solution 
by the walls of a container followed by a slower and 
essentially irreversible loss of the solute to the 
atmosphere in a bi—exponential manner described by the 
equation: 
F = Ae —at  + Be  B eqn 2.1 
where 	is the fraction of solute in solution, Vend B are 
the fractional 	zero 	intercepts 	(A+B=1) and „a andr,:-B are 
the faster and slower rate constants of disappearance. 
Monoexponential disappearance kinetics (equation 2.2) apply 
if the solute has only a low affinity for the material of 
the container and an insignificant amount of solute is 
therefore sorbed by the container wall: 
Fs = Ae —kt 	 eqn 2.2 
where k is the disappearance rate constant. 
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The two compartment closed model (equation 2.3) describes a 
reversible first-order 	process. 	The amount of drug 
remaining in solution at any time is given by the equation: 
(A
t 
- Aeq ) = in (Ao - Aeq ) - (k 12 4- k 21 )t 	eqn 2.3 
where A O , - 	A q — 	and lei - ) are Solution e' concentrations at zero, 
equilibrium and any time 't' respectively, and kr -2 -;and 1 
are rate constants of the forward and reverse reactions. 
Processes involving loss of a drug from solutions stored in 
plastic containers and which can be described by a two 
compartment 	model 	are 	assumed 	to 	be 	essentially 
partitioning processes. That is, the rate and extent of 
disappearance Of solutes from solutions stored in plastic 
containers are determined primarily by the transfer •of 
solute across the solution-plastic interface. It is 
assumed that "mixing" of the solute with the plastic 
container is instantaneous and complete so that transport 
within the plastic matrix does not constitute a 
rate-limiting barrier. 
(b) Diffusion Coefficient and the Diffusion Model 
Diffusion is the process by which matter is transported 
from one part of a system to another as a result of random 
molecular motions. 	The quantitative description of this 
process has been summarised 	in Fick's first law 
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diffusion: 
dc q = -DA TI 3i- eqn 2.4 
where q is the amount of material diffusing across a unit 
area A of a membrane per unit time, dc/dx the concentration 
gradient 	across 	the 	membrane 	and D the diffusion 
coefficient. In drug-plastic interactions involving 
sorption, the rate-determining step of the sorption process 
has been described as the diffusion of the drug molecules 
within the polymer (Autian, 1971). When the concentration 
(c) of the drug in the plastic is continually changing, 
Fick's second law (equation 2.5) is used to describe the 
rate of change of concentration. 
	
dc 	D d 2 c 	 eqn 2.5 
dt 
A solution to equation 2.5 has been provided by Crank 
(1948) and Carman and Haul (1954) (equation 2.6) and was 
derived from equations given to describe the sorption of 
solutes from a stirred solution of limited volume by a 
plain sheet: 
F t - Fm - Ecc 	2a(l+a)  eqn 2.6 1 - F 	n=1 1+a+a2 2 exP ( - qn
2 Dt/1 2 ) 
cc qn 
where a, equals F. /(1-F. ), q ns are the non-zero positive 
roots of tan qr. -aq, and D is the diffusion coefficient of 
solute in a plastic sheet of thickness 1. 	It is assumed 
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that (1) 	the concentration of solute sorbed by the plastic 
is proportional to the free concentration of solute, (2) 
diffusion of solute in the matrix of the plastic is the 
rate-determining step in the sorption process, (3) the 
properties of the plastic and the diffusion coefficient of 
the solute in the plastic remain unaltered during the 
sorption process, (4) the concentration of solute in the 
aqueous solution at any time is independent of position, 
and (5) sorption of solute by the plastic is restricted to 
the area in contact with solution. 
(c) Temperature Studies 
In both the diffusion model and the compartmental model the 
extent of uptake of drugs by and the rate of diffusion of 
.drugs in 	plastics 	is 	temperature 	dependent. 	This 
temperature dependence has been used 	to evaluate the 
mechanisms of interactions between solutes and plastics 
(Autidn, 	1971). 	The dependence 	of 	the 	diffusion 
coefficient 	(D) on temperature is usually evaluated using 
the Arrhenius relationship: 
D = D e —E /RT 	 eqn 2.7 
where IX, is a pre-exponential 	factor, 	the activation 
energy of diffusion, and 	R and T are the usual gas and 
temperature constants. The activation energy from this 
expression may be related to the movement of the polymer 
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chains in a particular plastic and 	the 	transport of 
molecules between those chains (Autian, 1971). The changes 
in the diffusion coefficient with temperature mainly 
account for the differences in the extent of sorption of 
any solute by a plastic at a given time. 
2.1.3. Delivery Systems 
The delivery systems used for parenteral solutions of drugs 
and which have been implicated in interactions with drugs 
are glass bottles, plastic syringes, plastic infusion bags 
and plastic giving sets. 
(a) Glass Bottles 
Numerous studies have documented the fact that insulin is 
• adsorbed onto glass surfaces. 	Ferrebee et al (1951) first 
reported insulin binding by laboratory glassware. 	However 
Weisenfeld et al 	(1968) were the first to study the 
adsorption 	insulin by glass intravenous 	infusion 
bottles. These workers found that prewashing the glass 
bottles with a 1% albumin solution overcame the loss of 
insulin by adsorption. Subsequent reports (Petty and 
Cunningham, 1974; Genuth, 1973; Weber et al, 1977) reported 
varying success using this technique. 
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(b) Plastic Syringes 
Nylon, polyethylene, polypropylene and polystyrene are the 
plastics used 	to make syringes. 	Autian and Brewer (1958) 
first reported a drug-plastic 	interaction involving a 
plastic syringe. 	Erythromycin in this case interacted with 
its solvent diethyl carbonate to degrade the syringe. 
Adrenalin, pr'omethazine, procaine and streptomycin have 
been shown to discolour polyethylene syringes (Guess et al, 
1965). 
(c) Plastic Infusion Bags 
The sorption of drugs by plastic infusion bags is well 
documented. 	Vitamin 	A acetate, 	sodium warfarin, 	and 
methohexltal (M6orhatch and 	Chiou, 	1974a), 	thiopentone, 
chlormethiazole and 	promethazine 	(Kowaluk et al, 	1981), 
insulin (Petty and Cunningham, 1974; 	Whalen 	et al, 1979; 
Weber 	et 	al, 	1977), 	and 	diazepam 	(Parker et al, 1979; 
Parker and MacCara, 1980; Cloyd et al, 1980) are drugs 
which have been shown to be appreciably sorbed by plastic 
infusion bags. 
Leaching of the plasticizer di-2-ethyl-hexyl phthalate 
(DEHP) from polyvinyl chloride infusion bags into blood and 
other solutions stored in the bags has also been reported 
(Whitlow et al, 1974; Jaeger and Rubin, 1972; Moorhatch and 
Chiou, 1974b). 
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(d) Plastic Giving Sets 
Like plastic infusion bags, plastic giving sets have been 
shown to be responsible for the sorption of a number of 
drugs. Insulin (Weisenfeld et al, 1968; Hirsch et al, 
1977; Whalen et al, 1979), diazepam (MacKichan et al, 1979; 
Cloyd et al, 1980; Parker and MacCara, 1980) and 
chlormethiazole (Tsuei 	et al, 1980) are sorbed by plastic 
giving sets. 	Cloyd et al (1980) 	are 	the only workers to 
have looked at the individual contributions of the 
cellulose propionate burette chambers and the polyvinyl 
chloride tubing of giving sets. 
2.2. DRUG INSTABILITY 
Drugs in parenteral 	solution are subject to 	several 
chemical degradative processes which can yield new and 
often therapeutically inactive or toxic by-products. 
Moreover, drugs may interact with other excipients in the 
same parenteral solution resulting in reduced availability 
of active therapeutic agent. 
2.2.1. Hydrolysis 
Hydrolysis is the most common chemical reaction responsible 
for drug degradation in parenteral 	solutions (Newton, 
1978). 	It is catalyzed by hydrogen ion, 	light, heat 	and 
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divalent metal cations. 
Functional groups most susceptible to hydrolysis are esters 
(Anschel 	et 	al, 	1972; 	Higuchi 	et 	al, 1950; Marcus and 
Taraszka, 1957; Schmid, 1961; Moffett and 	Garrett, 	1955), 
amides 	(Marcus and Taraszka, 1959), lactams (Chatterji 	et 
al, 1975; 	Savello 	and 	Shangraw, 	1971; Yamana and Tsuji, 
1976) and imines (Han et al, 1976, 1977). 
2.2.2. Oxidation 
• After hydrolysis the next most common pathway of drug 
degradation is oxidation. The most common form of 
oxidative decomposition is autoxidation through a free 
radical chain process (Mollica et al, 1978). 	Oxidation may 
be catalyzed by heavy metal 	ions, oxygen, hydrogen ions, 
hydroxyl ions, light and heat. 
Examples of drugs administered parenterally which can be 
affected by oxidation include the phenolic drugs morphine 
(Yeh and Lach, 1961) and 	phenylephrine (Newton, 1978), the 
catecholamine epinephrine (Hajratwala, 1975), the 
phenothiazines (Roseboom and Fresen, 1975; Underberg, 1978) 
and amitriptyline (Enever et al, 1975). 
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2.2.3. Photolysis 
Light can cause photochemical oxidation or hydrolysis of 
drugs in parenteral solution. 	Many examples of this have 
been reported (Newton, 1978; 	Lin 	and 	Lachman, 	1969). 	A 
photo-induced 	rearrangement 	reaction 	of 	sodium 
nitroprusside has also been reported (Frank et al, 1976). 
The ultraviolet and violet portions of the light spectrum 
are more active in initiating chemical reactions than light 
from the longer wavelength portions of the light spectrum. 
Because amber glass does not appreciably transmit light of 
wavelengths below about 500nm, it is used to effectively 
retard photolysis of drugs stored in glass. However, 
plastic polymers have functional groups (carbonyl 	and 
aromatic) 	which absorb 	ultraviolet light. 	Resulting 
degradation products such as hydroxyl or peroxide groups 0 
may 	tend 	to increase the absorption of ultraviolet 
wavelengths 	and 	hence 	accelerate 	any 	photolytic 
decomposition already occurring in the solution stored in 
the 	plastic 	(F.D.A. 	notes, 1974/75). 	For 	this 	reason 
plastic containers which are used to parenterally 
administer drugs which are susceptible to photolysis are 
covered with aluminium foil or other light-shielding 
material. 
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2.2.4. Drug-Excipient Interactions 
Incompatibilities arising from physicochemical phenomena 
can result in decreased potency of a drug in parenteral 
solutions. 	The incompatibility may be manifested as a 
drug-drug interaction 	(Parker, 1967; Newton, 1978; Edward, 
1967), a drug-vehicle interaction 	(Savello and Shangraw, 
1971; Blaug and Huang, 1973; Laegeler et al, 1974; 	Parker, 
1967), 	or a drug interaction involving complexation with 
metal cations (Price 	et 	al, 	1957; Prasad et al, 1974) or 
disodium 	EDTA 	(Kirschenbaum 	and 	Latiolais, 	1976). 
Interactions between drugs and antibacterial 	preservatives 
(Shoup, 1967) or antioxidants (Rork and Pitman, 	1975) also 
occur. 
Griffin and D'Arcy (1975) have presented a comprehensive 
list of incompatibilities of a number of classes of 
infusion fluids with additives as well as some common 
drug-drug interactions. 
2.2.5. Other Degradative Pathways 
Other chemical reactions responsible for the degradation of 
drugs 	in 	parenteral 	solution 	are isomerization of 
penicillins (Bundgaard, 1971), lincomycin monoesters 
(Oesterling and Metzler, 1972) and prostaglandins El and E2, 
(Monkhouse et al, 1973) and epimerization of tetracyclines 
(Schlecht and Frank, 1973) and 1-adrenalin (Hellberg, 
1955). 
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CHAPTER 3 - 
CHEMISTRY OF THE ORGANIC NITRATES 
3.1. SYNTHESES 
3.1.1. Nitroglycerin 
Nitroglycerin 	(1,2,3-propanetriol 	trinitrate, 	glycerol 
trinitrate, glonoin), which was first synthesized by 
Sobrero in 1847 (Urbanski, 1965), is a colourless oil which 
is prepared by the nitration of anhydrous glycerol with 
equal volumes of concentrated nitric and sulphuric acids 
(Boschan, 1955; Urbanski, 1965). Sulphuric acid is present 
because of its hygroscopic nature which prevents water 
formed in the reaction of glycerol and nitric acid from 
diluting the reaction mixture. Dilution of nitric acid 
leads to the formation of the dinitroglycerols (Urbanski, 
1965). 
3.1.2. Isosorbide Dinitrate 
Isosorbide 	dinitrate 	(1,4:3,6-dianhydro-D-glucitol 
2,5-dinitrate) is a colourless crystalline solid which is 
prepared by the nitration of the dianhydride of sorbitol by 
concentrated nitric and sulphuric acids (Krantz et al, 
1939a; Forman et al, 1941). 
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3.1.3. 	Ethylene Glycol Dinitrate 
Ethylene 	glycol 	dinitrate 	(1,2-ethanediol dinitrate, 
nitroglycol) (EGDN) is a colourless oil which is prepared 
by the nitration of ethylene glycol with concentrated 
nitric and sulphuric acids. It was first synthesized by 
Henry in 1870 (Rinkenbach, 1927). 
The structures of these organic nitrates are presented in 
Figure 3.1. 
3.2. 	PHYSICAL PROPERTIES 
Urbanski (1965) and Boschan (1955) have discussed in detail 
the physical properties of.the organic nitrates. The lower 
nitrate esters are colourless 	sweet-smelling liquids. 
Because of the presence of a semi-polar bond 	in the nitro 
group, liquid organic nitrates have higher vapour pressures 
than their corresponding alcohols. 
The organic nitrates have low water solubility. 	As the 
molecular weight of completely nitrated alcohols increases, 
water solubility decreases. They are very soluble in 
alcohol and other common organic solvents. 
Some physical constants of interest are presented in Table 
3.1. 
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NITROGLYCERIN 
CH 2 — 0 - NO2 
, CH — 0 — NO 2 
C H2 0 — NO 2 
ISOSORBIDE DINITRATE 
C 	 
H C 	 
NO2 — 0— C — H 
C H2 
H — C —0 — NO 2 
C H 
ETHYLENE GLYCOL DINITRATE 
C H27 0 NO 2 
CH 2 — 0 — NO 2 
Figure 3.1 Structures of the organic nitrates of 
interest. 
Table 3.1. Physical Constants of Organic Nitrates a 
COMPOUND 
Physical 	Molecular 	Specific 	Water 	Melting Vapourb 
State 	Weight 	Gravitx 	Solubility 	Point 	Pressure 
at (gm/cc) 	(g/litre (0C) (mm Hg at 
Room at 20°C) 	at 200 C) 20°C) 
Temp. 
ETHYLENE GLYCOL 
DINITRATE 
NITROGLYCERIN 
OIL 	152.03 	1.49 	6.8 	-22 	0.038 
OIL 	227.09 	1.60 	1.2-1.8 	2.2 
(labile) 0.00026 13.2 
(stable) 
ISOSORBIDE 
DINITRATE SOLID 	236.14 0.68 	68-71 
(a) Adapted from"Organic Nitrates i,' editor P. Needleman, Springer-Verlag (1975) p. 17. 
(b) Urbanski (1965). 
3.3. CHEMICAL STABILITY 
3.3.1. 	Nitroglycerin 
Nitroglycerin 	is hydrolyzed rapidly in alkaline solution. 
The hydrolytic reaction of nitroglycerin performed in an 
aqueous or alcoholic solution of sodium or potassium 
hydroxide results in the formation of organic acids, 
nitrates, 	nitrites, aldehyde resins and ammonia (Urbanski, 
1965). 	This alkaline hydrolysis reaction has been used by 
Fung et al 	(1973) 	to 	develop 	a 	kinetic assay of 
nitroglycerin in aqueous solutions (see Section 3.4.). The 
rate of alkaline hydrolysis is much greater than acid 
hydrolysis (Crew and DiCarlo, 1968). Nitric oxides are 
formed upon the oxidation of nitroglycerin by nitric acid. 
Boschan et al 	(1955) have reviewed the literature reports 
on the influence of temperature on the decomposition of the 
organic nitrates. Their review concentrated on ethyl 
nitrate. 
Waring and Krastins 	(1970) 	found 	that above 140 ° C the 
thermal 	decomposition 	of 	pure 	nitroglycerin 	is 
approximately first order in nature. 	Autocatalytic effects 
influence the rate constant as the reaction proceeds at 
this temperature. 	The rate of thermal decomposition of 
nitroglycerin is doubled 	for every 	increase 	in 
temperature from 95 ° C to 125 ° C (Urbanski, 1965). 
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The stability of nitroglycerin in various solvents has been 
studied 	by Suphajettra et al (1978). 	Absolute alcohol, 
propylene glycol, glycerol, povidone 	and polyethylene 
glycol 400 were the solvents studied. 	At the elevated 
temperatures of accelerated stability studies, considerable 
loss of nitroglycerin was demonstrated only in polyethylene 
glycol 400. 
Nitroglycerin appears to be unaffected by diffuse daylight, 
however concentrated ultraviolet rays in the 3200-4000nm 
range can initiate decomposition. The effect of heating 
previously irradiated nitroglycerin at 100C quickly raises 
the reaction rate (Urbanski, 1965). 
3.3.2. 	Isosorbide Dinitrate 
Krantz et al 	(1962) found that isosorbide dinitrate could 
not be hydrolyzed 	after 	treatment with 0.2N sodium 
hydroxide ,at 37?;C for 5 minutes. 	However, 	it has been 
reported that in alkaline and acidic media under vigorous 
hydrolytic conditions ,degradation of isosorbide dinitrate 
occurs (Silvieri and DeAngelis, 1975). Heating isosorbide 
dinitrate in 1N hydrochloric acid at 100°C for one hour 
resulted in 25% decomposition of the drug, and heating the 
drug in 1N sodium hydroxide at 100 iC for one hour resulted 
in 45% decomposition. 
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3.3.3. 	Ethylene Glycol Dinitrate 
Like nitroglycerin, ethylene glycol dinitrate is readily 
hydrolyzed in ethanolic or aqueous solutions of potassium 
or sodium hydroxide to give nitrite ion and glycolate. It 
is more stable in concentrated acids than nitroglycerin. 
Ethylene glycol dinitrate is hydrolysed to some extent by 
hot water (at 60C, 0.008% over 5 days), the degree of 
hydrolysis being more than that of nitroglycerin (Urbanski, 
1965). 
3.4. METHODS OF ANALYSIS OF THE ORGANIC NITRATES 
The earliest recorded method used to identify nitroglycerin 
involved ether extraction of the drug from the stomach of a 
cadaver, evaporation of the ether on an anvil and striking 
the extract with a hammer to see if it exploded (DiCarlo, 
1975). Methods of analysis of nitroglycerin have generally 
improved since the above technique was used. 
3.4.1. 	Colorimetry 
Bogaert 	(1975) 	and 	DiCarlo 	(1975) 	have 	reviewed' the 
colorimetric methods, of analysis of nitroglycerin. 	Other 
organic nitrates to be analyzed in this way are ethylene 
glycol 	dinitrate 	and 	1,2-propylene glycol dinitrate 
(Litchfield, 1968), 1-chloro-2,3-propanediol 	dinitrate and 
1,2,3-pentanetriol 	trinitrate 	(Bell 	et 	al, 	1963), 
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isosorbide dinitrate (Reed et al, 1971) and pentaerythritol' 
tetranitrate (Das Gupta, 1978; Hankonyi and 
Karas-Gasparec, 1969). 
After acid or alkaline hydrolysis of the parent compound to 
form nitrate or nitrite ion, the colorimetric reagents used 
include 	N-1-naphthylethylenediamine 	(Litchfield, 	1968; 
Bell et al, 1963), m-xylenol (Reed et al, 1971), 
phenoldisulphonic acid (Das Gupta, 1978) and p-nitroaniline 
and azulene (Hankonyi and Karas-Gasparec, 1969). 
3.4.2. 	Thin-Layer Chromatography 
Thin-layer chromatographic methods (TLC) 	used to assay 
nitroglycerin have been reviewed by Bogaert (1975) and 
DiCarlo (1975). Investigators have used TLC for the 
separation of explosive mixtures of mannitol hexanitrate, 
pentaerythritol tetranitrate, diethylene glycol dinitrate, 
ethylene glycol dinitrate, nitroglycerin 	and 	sorbitol 
hexanitrate 	(Parihar 	et 	al, 	1967), 	and 	to study 	the 
metabolism of pentaerythritol trinitrate in man (DiCarlo et 
al, 	1977; 	Davidson 	et 	al, 	1971), 	pentaerythritol 
tetranitrate 	in 	rats 	(Crew et al, 1975) 	and isosorbide 
dinitrate in dogs (Sisenwine and Ruelius, 1971). 
Quantitation of an organic nitrate and its metabolites has 
been facilitated by the use of radio-labeled parent 
compounds or by staining followed by densitometry. While 
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these methods are highly , specific they lack sufficient 
speed and sensitivity to be of use in routine analyses of 
either pharmaceutical preparations or biological fluids. 
3.4.3. 	Polarography 
It has been known 	since 	1933 that nitroglycerin 	is 
reducible at the dropping mercury electrode (Whitnack et 
al, 1955) and the mechanism of this reduction was studied 
by Kaufman et al (1952) and Radin and De Vries (1952). The 
behaviour of nitroglycerin, ethylene glycol dinitrate and 
pentaerythritol tetranitrate at the dropping . mercury 
electrode was reported by Whitnack et al (1954) prior to 
the same workers developing a method for extraction and 
polarographic analysis of nitroglycerin in double-base 
explosive powder (Whitnack et al, 1955). Ayres and Leonard 
(1959) modified 	the 	assay of Whitnack et 	al (1955) to 
determine the pentaerythritol 	tetranitrate content when 
present in propellants with nitrolgycerin. 
Following earlier work with the nitrate esters (Whitnack et - 
al, 	1954, 	1955), 	Whitnack 	(1975) applied 	single 	sweep 
polarographic techniques in the detection of trace amounts 
of nitroglycerin and 1,2-propylene glycol dinitrate 	in 
ground and surface waters. 
In the analysis of pharmaceutical preparations of nitrate 
esters, nitroglycerin has been assayed by both aqueous 
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(Flann, 	1969) 	and 	non-aqueous (Woodson and Alber, 	1969; 
Pugh, 	1979) 	polarography, while Turner and Lenkiewicz 
(1976) showed that isosorbide dinitrate and the two 
isosorbide mononitrates are polarographically reducible and 
applied this method in the analysis of isosorbide dinitrate 
in several tablet formulations. 
3.4.4. 	Infrared Spectroscopy 
Pristera et al 	(1960) 	described 	infrared spectra of 
nitroglycerin, 	pentaerythritol 	tetranitrate, 	ethylene 
glycol dinitrate and diethylene glycol dinitrate and 
mentioned techniques for the quantitative analysis of 
mixtures of these compounds as occur in explosives. 
Whereas ultraviolet spectroscopy has become more popular 
than infrared techniques for the analysis of the above 
nitrate esters, isosorbide dinitrate exhibits an 
ultraviolet 	spectrum 	of 	only 	low sensitivity 	and 
specificity. For this reason Woo et al (1973) developed an 
infrared spectrometry method for the analysis of isosorbide 
dinitrate in dosage forms. This method provided a lower 
limit of detection of 12 mcg/ml solution and was specific 
and rapid. 
3.4.5. 	Gas Chromatography 
The early history of the development of gas chromatography 
for the analysis of nitroglycerin has been reviewed by 
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Bogaert 	(1975) and DiCarlo (1975). 	Alley and Dykes (1972) 
used a gas chromatograph equipped with a flame ionization 
detector 	to determine the nitroglycerin 	content 	of 
pharmaceutical 	preparations. 	Shortly after this, Rosseel 
and 	Bogaert 	(1973a) 	reported a method, 	using 	an 
electron-capture detector, capable of detecting 
nitroglycerin levels as low as 0.5 ng/ml plasma after 
buccal administration of nitroglycerin to man. This method 
was similar to one earlier reported by Sherber et al (1970) 
for the analysis of isosorbide dinitrate in rabbit blood 
except that Sherber et al (1970) used a flame ionization 
detector and consequently could only achieve a limit of 
detection for isosorbide dinitrate of 100 ng/ml plasma. 
The method of Bogaert and Rosseel (1973a) has been the 
mainstay of analysis of nitroglycerin and isosorbide 
dinitrate in plasma with only modifications of the method 
(Blumenthal et al, 1977; Yap et al, 1978; Givant and 
Sulman, 1978; Armstrong et al, 1979; Wei 	and 	Reid, 	1979; 
Assinder et al, 1977; Malbica et al, 1977; Laufen et al, 
1978, Doyle et al, 1980) being subsequently reported in the 
literature. Other modified methods have been used in the 
analysis of 1,2- and 1,3-glyceryl dinitrates and 1- and 
2-glyceryl mononitrates in blood (Neurath and Dunger, 
1977), isosorbide 1- and 5-mononitrates in plasma (Richard 
et al, 1976; 	Chin 	et al, 1977; Rosseel and Bogaert, 1979) 
and nitroglycerin in 	intravenous 	fluids 	(Sturek et al, 
1978). 
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Other organic nitrates to be separated or quantitated by 
gas chromatography are ethylene glycol dinitrate (Camera 
and 	Pravisani, 	1964; 	Williams 	et 	al, 1966; Litchfield, 
1968), 	diethylene glycol 	dinitrate, 	triethylene 	glycol 
dinitrate, 1,5-dinitropentanediol (Camera and Pravisani, 
1964), ethylene glycol mononitrates and propylene glycol 
di- and mononitrates (Litchfield, 1968), pentaerythritol 
tetra-, tri-, di- and mononitrates (Davidson et al, 1971) 
and isomannide and isoidide dinitrates and mononitrates 
(Rosseel and Bogaert, 1972; Rosseel and Bogaert, 1973b). 
3.4.6. 	Kinetic Assay 
A kinetic method for the analysis of nitroglycerin in 
dosage forms was reported by Fung et al (1973) to be 
simpler than gas chromatographic and polarographic methods.•
Moreover the other simple method of analysis of 
nitroglycerin, the colorimetric method of Bell et al 
(1963), was reported by Morrison and Fung (1979) to be 
affected by inorganic nitrite ion. 
Fung et al 	(1973) 	found 	that nitroglycerin degrades in 
alkaline methanolic solution in a stepwise mode with the 
formation of a chromophoric intermediate which has a 
wavelength of maximum absorbance of 328nm. The assay is 
unaffected by the presence of glycerol, nitrate and nitrite 
ions up to a concentration of 0.01M, and glyceryl 
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dinitrates and glyceryl mononitrates 	(Yap et al, 1975b). 
The kinetic assay was shown by Yap et al (1975a) to be also 
suitable for the determination of erythritol tetranitrate, 
pentaerythritol tetranitrate and mannitol hexanitrate in 
dosage forms. Waaler et al (1977) adapted this method to 
the automated analysis of nitroglycerin in tablets. 
3.4.7. 	High-Pressure Liquid Chromatography 
Normal phase high-pressure liquid chromatography (HPLC) has 
been 	used 	for the separation and 	identification of 
nitroglycerin and 	its dinitro metabolites in waste waters 
from an ammunitiOn plant (Chandler et al, 1974) and for the 
separation and identification of nitroglycerin •and 	its 
stabilizers and 	plasticizers in explosives (Doali 	and 
Juhasz, 1974). 	The 	findings of Camera and 	Pravisani 
(1964), 	showing that nitroglycerin appreciably decomposed 
while on the column of a gas chromatograph, made it 
apparent that the analysis of thermally labile nitrate 
esters 	would be more suited to high-pressure liquid 
chromatography. 	Moreover, because of the non-destructive 
nature of the analysis by ultraviolet detection, subsequent 
analysis of any separation product could be performed. 
These advantages 	are 	offset, however, by the great 
reduction in sensitivity of ultraviolet and 	fluorescence 
detectors when compared to electron-capture detection in 
conjunction with gas. chromatography. 	The method produced 
by Chandler 	et al 	(1974) resulted in a lower level 	of 
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detection of 10 mcg/ml water for nitroglycerin and its two 
dinitro metabolites. 	Both the above HPLC methods required 
extraction of water samples (Chandler et al, 1974) or 
propellant mixtures (Doali & Juhasz, 1974) with methylene 
chloride. 
Pentaerythritol, 	a 	metabolite 	of 	pentaerythritol 
tetranitrate, was analyzed as the tetra-p-methoxybenzoate 
derivative using an HPLC method that resulted in a lower 
limit of detection of pentaerythritol equivalent to about 2 
mcg/ml plasma (Bighley et al, 1975). Solvent extraction of 
plasma by a mixture of heptane and chloroform was necessary 
in this method. 
The 	analysis 	of 	nitroglycerin 	in dosage forms by 
reversed-phase HPLC was first performed by Crouthamel and 
Dorsch (1979). This method using a mobile phase of 40% 
methanol-water and C18 column was the first to resolve 
nitroglycerin, 1,2- and 1,3-dinitroglycerins and 1- and 
2-mononitroglycerins. 	The lower limit of detection of 
nitroglycerin was 3 mcg/ml water. 
Another HPLC assay procedure for nitroglycerin in tablet 
and intravenous dosage forms was reported by Baaske et al 
(1979). This assay used an alkyl phenyl column and an 
acetonitrile-water 	mobile phase for 	separation and a 
detection wavelength of 218nm. 	Isosorbide dinitrate was 
used as the internal standard for quantitation. 
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Fan et al (1978) described a method 	for 	the analysis of 
ethylene glycol dinitrate esters in water by means of a 
thermal energy analyzer and this method was applied by 
Spanggord and Keck (1980) to the analysis of nitroglycerin 
and its four metabolites in dogs' blood. Separation of all 
the degradation products from the parent compound was 
achieved on a Lichrosorb S-60 column using a gradient 
elution technique. Trace levels of organic nitrates in 
explosives were also identified using HPLC with a thermal 
energy analyzer (Lafleur and Morriseau, 1980). 
35 
CHAPTER 4 
rt. 
EXPERIMENTAL 
4.1. MATERIALS 
4.1.1. Chemicals 
Acetic acid, glacial, analytical reagent, Ajax 
Chemicals, 62055 
ammonium hydroxide, analytical reagent, Commollwealth 
Ammonia Corporation 
benzene, analytical reagent, Ajax Chemicals 
chlormethiazole edisylate, Astra Pharmaceuticals, DC 1750, 
lot 8976 
diazepam, Roche Products 
diethyl ether, analytical reagent, Ajax Chemicals, 64052 
diphenylamine, British Drug Houses 
ethyl acetate, analytical reagent, Ajax Chemicals, 82837 
ethylene glycol dinitrate (5% w/v), I.C.I. Operations 
hexane, spectroscopic grade, Ajax Chemicals, 83092 
isosorbide dinitrate, 40% on lactose, Schweiz 
isosorbide mononitrates, Ayerst Laboratories 
methanol, analytical reagent, Ajax Chemicals, 83248 and 
chromatographic grade, Waters Associates, 24626M 
nitroglycerin (5% v/v), Dept. Manufacturing Industry 
octanol, laboratory quality, BDH Chemicals, 29409 
phenol, analytical reagent, May and Baker, 45693 
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potassium nitrate, analytical reagent, By-Products 
and Chemicals, 50506 
silica gel, GF, Sigma Chemical Company, lot 25C-0219 
sodium hydroxide, Volucon N/1, May and Baker, lot A9 
sulphuric acid, concentrated, analytical reagent, Ajax 
Chemicals, 303308 
4.1.2. General 
All 	glassware was washed 	in 	'Pyroneg', 	rinsed 	with 
distilled water and then washed with methanol before drying 
in an oven at 70 ° C. The distilled water used throughout 
was produced by a Buchi all-glass still. 
Plastic intravenous infusion bags (Viaflex, code AHB1323) 
and plastic giving sets (Buretrol, code 2C0133 and AHC0132) 
were received from Travenol Industries, Melbourne. 
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High density polyethylene tubing ('Intramedic 	PE50', 	Clay 
Adams, New Jersey) was attached to the outlet of a 50m1 
interchangeable glass syringe (Ultra-Asept, West Germany) 
which was driven by an infusion pump (Type 871104, B. 
Braun,. Melsungen). 
Because the concentration of nitroglycerin in the 5m1 
bottles supplied varied from bottle to bottle, the 
nitroglycerin content of each bottle was standardized'using 
the method of Dean and Baun (1975). 
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Isosorbide dinitrate (40%) on lactose was purified by ether 
extraction of the powder and recrystallization from an 
ethanol/water mixture. 
Ethylene glycol dinitrate was used as received (500mls of 
5% w/v EGDN in ethanol). 
4.2. STORAGE STUDIES AND SIMULATED INFUSIONS 
4.2.1. Plastic Infusion Bags 
Glass syringes were used to transfer known volumes of 
ethanolic stock solutions of nitroglycerin, isosorbide 
dinitrate or ethylene glycol dinitrate through the 
administration port of infusion bags containing 500mls of 
either 5% dextrose in water, normal saline or water. The 
solutions were mixed thoroughly by drawing solution into 
the barrel of a glass syringe and then squirting the drawn 
solution back into the contents of the bag. This process 
was repeated 	several 	times. 	An aliquot of solution was 
removed 	immediately after mixing and 	this sample was 
regarded as the zero-time sample. 	All air was removed from 
the contents of each bag. Bags were then supported in an 
upright position so that all exterior surfaces were exposed 
to the air. 	Thereafter samples were taken from the aqueous 
solutions in the bags, after mixing in the above-mentioned 4' 
way, at known time intervals. 
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When the effect of the volume of drug solution on the loss 
of nitroglycerin from solution stored in the plastic bags 
was investigated, various volumes were initially removed 
from the bags and known volumes of stock drug solutions 
were added to the remaining solution so that all volumes 
studied were equivalent in drug concentration. Studies of 
the loss of the test drugs from their aqueous solutions 
stored in plastic infusion bags were performed over a range 
of temperatures, however "volume effect" studies were only 
performed at ambient temperature (20°-24 ° C). 
4.2.2. Isolated Burettes of Plastic Giving Sets 
Storage studies involving the 	loss of nitroglycerin, 
isosorbide dinitrate or ethylene glycol dinitrate from 
aqueous solutions stored in the isolated burettes of giving 
sets were performed in a similar manner to studies using 
the infusion bags (Section 4.2.1.) except that accelerated 
stability testing was not undertaken. The burettes were 
separated from the giving sets and their outlets were 
closed with metal screw clamps. The burette holds a maximum 
volume of 150mls of solution and this volume was normally 
used except when studying a possible "volume effect" on the 
loss of nitroglycerin from solution. In this case, 
different volumes of the same drug solution were added 
directly to the burette. Studies were performed at ambient 
temperature (20P-24°C). 
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4.2.3. Plastic Infusion Tubing 
The disappearance of nitroglycerin from aqueous solutions 
stored in the plastic infusion tubing of the giving sets 
was studied using 2-cm lengths of polyvinyl chloride tubing 
filled with aqueous nitroglycerin solution. Both ends of 
each piece of tubing were closed by means of metal screw 
clamps. A series of pairs of pieces of tubing was set up so 
that at each sampling time the drug solution from a new 
pair was sampled. This method was necessary because the 
kinetic assay of nitroglycerin (see Section 4.6.1.) used a 
large proportion of the test solutions stored in the small 
pieces of tubing. These studies were performed at ambient 
temperature (207,-24C). 
All storage studies were performed at least in duplicate. 
As well, an aliquot of the test solution, sampled at zero 
time, was stored in glass bottles with metal screw caps and 
analyzed for drug content at intervals throughout the 
duration of each storage experiment. 
4.2.4. Simulated Infusions 
(a) Plastic Giving Sets 
The 	simulated 	infusion 	.of 	aqueous 	solutions 	of 
nitroglycerin and isosorbide dinitrate to patients was 
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performed using glass infusion bottles or plastic 	infusion 
bags connected to either whole giving sets or the isolated 
tubing of giving sets. 
For all studies in which burettes were employed, the volume 
of drug solution in the burette was maintained at 100m1. 
Drug solution was allowed to initially flow from the glass 
bottle or plastic bag through the tubing of the intact 
giving set or the isolated tubing until 5 drops of effluent 
were collected. By means of a measuring cylinder and a 
stop watch, a desired flow rate was then set. Infusion 
rates were controlled manually and were checked regularly 
to maintain a constant flow rate. 
(b) High Density Polyethylene Tubing Connected to a Glass 
Syringe 
Nitroglycerin, 	isosorbide 	dinitrate, 	diazepam 	and 
chlormethiazole solutions were pumped from a 50m1 glass 
syringe via a high density polyethylene cannula (80 x 
0.15cm). 	The glass syringe was driven by a Braun 	infusion 
pump to give a predetermined constant flow rate. 	Effluent 
was collected from the end of the tubing for analysis. 
All simulated 	infusions were performed in duplicate at 
ambient temperature (20-24 9 C). 
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4.3. KINETIC STUDIES WITH PLASTIC SHEETS AND TUBING 
4.3.1. Sorption Studies 
Pieces of polyvinyl 	chloride 	infusion bag (lcm x 	lcm), 
cellulose propionate burette (lcm x lcm) and finely cut-up 
high density polyethylene tubing (2cm) were carefully 
weighed before being immersed in 5m1 (polyvinyl chloride 
and cellulose propionate samples) 	or 0.4ml (high density 
polyethylene tubing) of aqueous drug solution. 	Solutions 
were stored in glass-stoppered 10 or lml glass tubes which 
were shaken vigorously at regular intervals throughout the 
course of the experiments. 	Aliquots of solution were 
removed from the containers at the beginning 	of an 
experiment and again at known intervals thereafter until 
equilibrium was reached. Solutions were stored in duplicate 
at 4+/-1C, room temperature (20°,-24C), 37,°)+/-1?C, 
45 ° +/-1C and 60°, +/-1C. 
4.3.2. Permeation Studies 
Studies were designed to determine whether the loss of any 
of the three organic nitrates from their aqueous solutions 
stored in contact with the polyvinyl chloride infusion bags 
was due to permeation of the drug through the plastic bag 
into the external 	environment and these studies involved 
using the apparatus depicted in Figure 4.1. 	The diffusion 
112 
20 mm 
I -4-- 32 mm 
78 mm 
32Mm 
DRUG SOLUTION 
PVC 	 
METAL COVER 
Figure 4.1 Diagrammatic representation of the 
apparatus used in permeation studies. 
The PVC sheet is held sandwiched between 
the drug solution and the metal cover 
by a metal clamp. 
cell 	had 	pieces of polyvinyl chloride (3.5cm x 3.5cm x 
0.039cm), cut 	frOm infusion bags, 	held firmly in place 
across the well of the diffusion cell by means of either 
annular or solid 	square sheets of stainless steel and a 
metal clamp. 	The solid metal sheets were intended to 
prevent drug molecules escaping to the outside air, while 
the annular sheets were intended to not inhibit the passage 
of drug molecules to the outside air. 
Aliquots of drug solutions were removed for analysis from 
the neck of the apparatus. Solutions of nitroglycerin were 
stored in the diffusion cells at room temperature and 
45+/-1C while solutions of isosorbide dinitrate and 
ethylene glycol dinitrate were stored at only 450+/-1?,C. 
All tests were performed in duplicate. 
4•4. 	PARTITION COEFFICIENTS 
Two millilitres of hexane or octanol, previously saturated 
with water, 	were pipetted 	into a 10m1 glass tube. 	Five 
millilitres of 	solution of known concentration 	of 
nitroglycerin, isosorbide dinitrate or ethylene glycol 
dinitrate in water (saturated with hexane or octanol prior 
to adding the test drugs) were added and the tubes 
stoppered. Containers were stored at a range of 
temperatures and were shaken vigorously at regular 
intervals. Aliquots were removed from the aqueous phase 
periodically for analysis until equilibrium was reached. 
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Octanol-water and hexane-water partition coefficients were 
calculated as the ratio of equilibrium concentrations of 
the three test drugs in the organic phase and in the 
aqueous phase. Plastic-water partition coefficients were 
calculated using the results of the equilibrium sorption 
studies (see Section 4.3.). The concentrations of drugs in 
the plastic and in the aqueous solutions were calculated as 
weight of drug per weight of plastic or water. 
4.5. DRUG METABOLITES 
Because authentic samples of the glyceryl dinitrates and 
ethylene glycol mononitrate were not commercially 
available, they were obtained by means of incubating 
nitroglycerin or ethylene glycol dinitrate with fresh human 
blood (Lee, 1973; Clark and Litchfield, 1967). 
About 500mcg of nitroglycerin or ethylene glycol dinitrate 
was added to 10m1 of fresh human blood and the mixture was 
incubated at 37;!W for one hour. 	Diethyl ether (2m1) was 
used to extract 1m1 aliquots of the blood and 20 
microlitres (ul) of this extract was injected directly into 
the HPLC system. These metabolites were needed so that 
their retention times during HPLC could be obtained in case 
possible hydrolysis products of the parent drug in solution 
produced interfering peaks in the chromatograms. 
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4.6. ANALYTICAL METHODS 
4.6.1..Kinetic Assay 
For initial work involving the loss of nitroglycerin from 
aqueous solutions stored in plastic infusion bags, burettes 
of giving sets and plastic tubing, a modified version of 
the kinetic assay of Fung et al (1973) (see Section 3.4.6.) 
was used. 	One millilitre of test aqueous solution was 
mixed with 2m1 of 0.6N methanolic sodium hydroxide. 	In the 
present work, a blank solution consisting of 1m1 of sample 
and 2m1 of water was used for reference. 
The composition of methanolic sodium hydroxide solution was 
as follows: 
1N NaOH 	 60m1 
Methanol  28m1 
Water 	  12m1 
Analyses were performed on a Cecil Instruments Ultraviolet 
Spectrophotometer Model CE202. 
4.6.2. High-Pressure Liquid Chromatography 
A modified version of two previously reported methods for 
the 	analysis 	of nitroglycerin in aqueous 	solutions 
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(Crouthamel and Dorsch, 	1979; Baaske et al, 1979) was used 
for the analysis of nitroglycerin, isosorbide dinitrate and 
ethylene glycol dinitrate. 
Aliquots (20u1) of the sample solutions were injected into 
a Waters Associates high-performance liquid 	chromato'graph 
equipped with a Micro-Bondapak C18 column (Waters). 	A 
mobile phase of water and methanol (60:40) was pumped at a 
flow rate of 2 ml/min. A Waters Model 450 Variable 
wavelength detector set at 218nm was used for quantitation. 
Standard curves were constructed with and without the use 
of a standard reference compound. 	When a reference 
compound was used it was one of the two organic nitrates 
not under examination at the time. 	In this case 200u1 of 
the reference solution (500 mcg/ml) 	was added to 1m1 of 
test solution and the mixture was vortexed for 10 seconds 
before a 20u1 aliquot was removed and injected into the 
chromatographic system. The ratio of peak heights of the 
test and reference compounds was then calculated and the 
concentration of test drug was read from a standard curve. 
When a reference compound was not used, the peak height (in 
mm) of the test drug was measured and its concentration was 
read from a standard curve. 	When this method was used to 
analyze solutions in contact with plastic 	for extended 
periods, the method was periodically calibrated by use of 
stock solutions of three known concentrations of the test 
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drugs. 
4.6.3. Spectrophotometry 
Aqueous solutions of chlormethiazole and diazepam were 
analyzed by spectrophotometric methods. Chlormethiazole 
was diluted 1 to 200 with water and the optical density 
measured at a wavelength of 257nm. Diazepam samples were 
diluted 1 to 1 with 0.2N H 2 SO4 and the optical density 
measured at a wavelength of 275nm. 
4.6.4. Thin-Layer Chromatography 
To 	authenticate 	the products of the incubation 	of 
nitroglycerin or ethylene glycol dinitrate in fresh human 
blood (Section 4.5.), diethyl ether extracts of the 
incubation mixture were spotted onto silica gel plates and 
developed using the method of Needleman and Hunter (1965). 
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CHAPTER 5 
RESULTS 
5.1. ANALYTICAL METHODS 
5.1.1. Kinetic Assay 
The composition of reactant solution used for the kinetic 
assay (see Section 4.6.1.) resulted in a maximum absorbance 
at about 5 minutes for nitroglycerin in water or normal 
saline solution, and at about 6 minutes for nitroglycerin 
in 5% dextrose in water solution. 
Standard curves constructed 	for nitroglycerin in water, 
normal saline and 5% dextrose in water solutions are shown 
in Figure 5.1. The level of detection was less than 3 
mcg/ml solution and linearity was observed down to a 
concentration of about 10 mcg/ml solution. Below this 
concentration the calibration plot curved to pass through 
the origin. 
5.1.2. High—Pressure Liquid Chromatography 
The mobile phase and flow rate used in this work (see 
Section 4.6.2.) 	gave retention times for ethylene glycol 
dinitrate, isosorbide dinitrate 	and 	nitroglycerin of 5.8, 
7.0 and 9.5 minutes respectively (Figure 5.2). 
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Standard curves constructed both with and 	without a 
reference compound were linear in the range 0-400 mcg/ml 
solution and passed through the origin (Figures 5.3, 5.4, 
5.5). 	The limit of detection of nitroglycerin, isosorbide 
dinitrate and ethylene glycol dinitrate was less than 	1 
mcg/ml solution. 
The results of the reproducibility 	studies 	for the 
quantitation of nitroglycerin, 	isosorbide dinitrate 	and 
ethylene glycol dinitrate with and without a reference 
compound are presented in Table 5.1. 	These show that the 
assays are both accurate and precise. 	Therefore an 
internal standard was not routinely used. 
The organic nitrates can be assayed by a number of 
techniques 	(see 	Section 	3.)4.) 	but 	apart 	from 	gas 
chromatography and high-pressure liquid chromatography 
there is no method by which nitroglycerin, isosorbide 
dinitrate and ethylene glycol dinitrate as well as their 
degradation products can be measured using exactly the same 
analytical conditions. Gas chromatography, however, would 
involve time-consuming extraction from aqueous solutions 
into an organic solvent. For this reason, a high-pressure 
liquid chromatography assay was chosen. 
The hydrolysis products of the three parent drugs had 
different retention times to each of the respective parent 
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drugs. 	However, if isosorbide dinitrate was used 	as an 
internal standard for the quantitation of nitroglycerin, it . 
had 	a similar retention 	time as that of 1,3-glyceryl 
dinitrate, a potential hydrolysis product of nitroglycerin. 
This problem was not encountered in practice because an 
internal standard was not routinely used. 
The three parent 	organic 	nitrates displayed greater 
absorbance at a wavelength of 218nm than at 200nm which is 
very close to the cut-off point for the methanol used 	in 
the mobile phase. 	Samples from bags containing only 5% 
dextrose in water, normal saline or water produced no 
extraneous peaks in the chromatograms. 
5.1.3. Comparison of Kinetic and HPLC Methods 
To determine the precision of the HPLC method of analysis 
of nitroglycerin compared to the kinetic assay, standard 
solutions of nitroglycerin containing 200 mcg/ml and 50 
mcg/ml were assayed 10 times by both methods. The results 
are given in Table 5.2. The precision of the two methods 
is similar. 
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Figure 5.1 Standard curves for the kinetic assay of nitroglycerin in 5% 
dextrose in water (0), normal saline (A) and water (o). 
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Figure 5.2 High-pressure liquid chromatogram of a 
• mixture of nitroglycerin (GTN), isosorbide 
dinitrate (ISDN) and ethylene glycol 
dinitrate (EGDN) at final concentrations 
of 80 mcg/ml water. 
(Chromatographic conditions are given in 
the text). 
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Figure 5.3 Standard curve for the HPLC assay of nitroglycerin using peak 
height ratio (peak height of drug/peak height of internal 
standard,isosorbide dinitrate) (4k) and absolute peak 
height (0). 
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Figure 5.4 Standard curve for the HPLC assay of isosorbide dinitrate using 
peak height ratio (peak height of drug/peak height of internal 
standard, ethylene glycol dinitrate) (A) and absolute peak 
height (0). 
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Figure 5.5 Standard curve for the HPLC assay of ethylene glycol dinitrate 
using peak height ratio (peak height of drug/peak height of 
internal standard t isosorbide dinitrate) (A) and absolute 
peak height (0). 
Table 5.1. Reproducibility of the HPLC assay of nitroglycerin 
(GTN), isosorbide dinitrate (ISDN) and ethylene glycol dinitrate 
(EGDN) based on peak height ratio (PR) of organic nitrate to 
internal standard and on absolute peak heights (PH). 
Parameter 
GTN 
PR 	PH 
ISDN 
PR 	PH 
EDGN 
PR 	PH 
Mean concentration 
(mcg/ml) 
Standard deviation 
CV, 	% 
200.1 
1.73 
0.86 
199.9 
1.95 
0.97 
199.5 
2.27 
1.13 
200.1 
2.09 
1.04 
200.1 
1.79 
0.89 
199.6 
1.82 
0.91 
Mean concentration 
(mcg/ml) 
Standard deviation 
CV, % 
49.7 
0.97 
1.83 
50.2 
0.83 
1.66 
49.9 
0.91 
1.82 
49.5 
0.93 
1.87 
49.7 
0.81 
1.63 
50.0 
0.76 
1.53 
Table 5.2. Comparison of the Reproducibility of 
the Kinetic and HPLC Assays for Nitroglycerin 
Parameter 
Kinetic 
Assay 
n=10 
HPLC 
Assay 
n=10 
Mean concentration 
(mcg/m1) 
Standard deviation 
CV, 	% 
200.0 
1.66 
0.83 
199.9 
1.95 
0.97 
Mean concentration 
(mcg/ml) 
Standard deviation 
CV, 	% 
50.1 
0.76 
1.52 
50.1 
0.83 
1.66 
5.2. STORAGE STUDIES AND SIMULATED INFUSIONS 
5.2.1. , Initial Infusion 
At the Royal Hobart Hospital infusions of nitroglycerin are 
usually commenced at a flow rate of 0.04 ml/min 	(16 
mcg/min). 	The rate is then doubled every 5 minutes until a 
maximum flow rate of 0.64 ml/min (256 mcg/min) is reached. 
The infusion is maintained at this maximum flow rate 
thereafter. The results of this simulated study using 
plastic infusion bags and giving sets are shown in Figure 
5.6. There was an initial rapid decrease in the 
concentration of nitroglycerin in the effluent followed at 
longer times by a small increase in the concentration of 
nitroglycerin up to a relatively stable plateau level which 
was maintained throughout the Thr simulated infusion. 
5.2.2. Vehicle 
The time course of loss of nitroglycerin, isosorbide 
dinitrate and ethylene glycol dinitrate from solutions 
stored in plastic infusion bags, isolated burettes of 
giving sets or plastic tubing of giving sets at room 
temperature is shown in Figures 5.7 to 5.11. The loss was 
independent of the nature of the vehicle, the profiles for 
any one drug being similar for drug solutions in 5% 
dextrose in water, normal saline and water. 
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Drug solutions stored in glass under the same conditions 
lost no potency. 
5.2.3. Concentration 
The percentage of nitroglycerin, 	isosorbide dinitrate and 
ethylene glycol dinitrate remaining in aqueous solutions 
stored in plastic infusion bags or isolated burettes of 
giving sets was independent of the concentration of drug in 
the range 100 mcg/ml to 1000 mcg/ml. Representative 
profiles of loss of these drugs are illustrated in Figures 
5.7 to 5.10. 
No loss of the test drugs Occurred when drug solutions were 
stored in glass. 
5.2.4. Volume 
Figure 5.12 shows the effect of solution volume on the 
percentage of nitroglycerin remaining in solutions stored 
in infusion bags and burettes for various times. For the 
infusion bags, the percentage of nitroglycerin remaining in 
solution decreased more rapidly for the smaller volumes 
(Figure 5.12a). The percentage of nitroglycerin remaining 
in aqueous solutions stored in the burettes for various 
times appears to be independent of the volume of solution 
in the burette (Figure 5.12b). 
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5.2.5. Temperature 
The effect of temperature on the loss of nitroglycerin, 
isosorbide dinitrate and ethylene glycol dinitrate from 
their aqueous solutions stored in plastic infusion bags is 
seen in Figures 5.13 to 5.15. The rate of loss was slowest 
at /-1°;C and this 	rate 	increased markedly with increasing 
temperature. 
Nitroglycerin and ethylene glycol dinitrate were completely 
lost from solution at the higher temperatures. However, 
isosorbide dinitrate was not completely lost from solution 
even at 60 ° 
There was no loss of any of the test drugs when stored in 
glass at elevated temperatures. 
5.2.6. Light 
There were no differences in the rate or extent of loss of 
nitroglycerin when 100 mcg/ml and 500 mcg/ml nitroglycerin 
solutions were stored in plastic infusion bags in the dark 
or in room light at ambient temperature. 
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5.2.7. Flow Rate 
(a) Nitroglycerin 
The flow rate dependent loss of nitroglycerin from aqueous 
solutions being infused from glass bottles through giving 
sets is illustrated in Figure 5.16. The percentage of the 
original nitroglycerin concentration which remained in the 
eluting solution was greater at faster flow rates. 
Nitroglycerin concentration decreased rapidly within the 
first hour at all the flow rates used, but with the faster 
flow rates, a subsequent increase occured before a plateau 
level was reached. For the fastest flow rate this level 
was about 70% of the original nitroglycerin concentration. 
When solutions of nitroglycerin were infused from glass 
bottles through plastic infusion tubing, the 	concentration 
of nitroglycerin in the effluent diminished immediately 
after beginning the infusion and 	then gradually.increased 
for longer times (Figure 5.17a). 	The cumulative amount of 
nitroglycerin sorbed by the infusion tubing at different 
flow rates is plotted as a function of time in Figure 
5.17b. 
Figure 5.18a illustrates the loss of nitroglycerin 	from 
solutions infused from various systems at a constant flow 
rate. In Figure 5.18b the cumulative amount of 
nitroglycerin sorbed by the components of the various 
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Figure 5.6 Initial simulated infusion of nitroglycerin 
(GTN) from plastic infusion bag through 
plastic giving set at a variable flow 
rate (see text for details). 
100 
90 
80 
ON!: 
50 
40 
20 	40 	60 	80 
TIME (HRS) 
Figure 5.7 Percentage of nitroglycerin (GTN) remaining in 
solutions stored in plastic infusion bags for 
original nitroglycerin concentrations of 100 
mcg/ml (open symbols) and 1000 mcgiml (closed 
symbols). 0 • water; o •5% dextrose in water; 
• normal saline. 
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• Figure 5.8 Percentage of isosorbide dinitrate (ISDN) 
remaining in solutions stored in plastic 
infusion bags for original isosorbide 
dinitrate concentrations of 100 mcg/ml 
(open symbols) and 1000 mcg/ml (closed 
symbols). 0 • water; o • 5% ,dextrose 
in water; 0 • normal saline. 
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Figure 5.9 Percentage of ethylene glycol dinitrate 
(EGDN) remaining in solutions stored 
in plastic infusion bags for original 
concentrations of ethylene glycol 
dinitrate of 100 mcg/ml (open symbols) 
and 1000 mcg/ml (closed symbols). 
0 • water; o • 5% dextrose in water; 
0. normal saline. 
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Figure 5.11 Percentage of nitroglycerin (GTN) 
(200 mcg/ml of water). remaining in 
solutions stored in plastic infusion 
tubing. 
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'.Figure 5.12 .Effect of volume of nitroglycerin 
(GTN) solutions (200 mcg/ml water) 
• stored in plastic infusion bags 
•(a) and burettes (b) on:the - 
percentage of nitroglycerin 
• remaining in solution. • 10 ml; 
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Figure 5.13 Effect of temperature on the percentage of nitroglycerin (GTN) 
remaining in solutions stored in plastic infusion bags. • 4°C; 
• room temperature (20° - 24°C); • 37°C; 0 45°C; A 60°C. 
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Figure 5.14 Effect of temperature on the percentage of isosorbide dinitrate 
(ISDN) remaining in solutions stored in plastic infusion bags. 
• 4°C; • room temperature (20° - 24 0 C); A 37°C; 0 45°C; A 60°C. 
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Figure 5.15 Effect of temperature on the percentage of ethylene glycol 
dinitrate (EGDN) remaining in solutions stored in plastic 
infusion bags. • 4°C; • room temperature (20° - 24°C); 
• 37°C; 0 45°C; A 60°C. 
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Figure 5.16 Effect of flow rate of the drug 
solution on the percentage of 
nitroglycerin remaining in 
solution after passage through 
plastic giving sets. • 0.91 ml/min; 
A 0.30 ml/min; • 0.17 ml/min; 
0 0.07 ml/min. 
10 	15 	20 25 
Cu
mu
la
ti
v e
  
TIME (HRS) 
Figure 5.17 (a) Percentage of original nitroglycerin (GTN) 
concentration in the effluent for, solutions 
infused from a glass infusion bottle through 
plastic infusion tubing at constant flow 
rates. -- - -- 0.75 ml/min; - - - 0.52 ml/min; 
— 0.23 ml/min. 
(b) Cumulative amount of nitroglycerin sorbed 
by the tubing for these flow rates. 
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Figure 5.19 Percentage of original isosorbide dinitrate 
concentration (ISDN) in the effluent at 
various times for solutions infused using 
(a) infusion bag/giving set, (b) glass 
bottle/giving set and (c) glass bottle/ 
infusion tubing. v 1.60 ml/min; 0 0.73-0.78 
ml/min; • 0.2 ml/min. 
Table 5.3. Comparison of recoveries of nitroglycerin (GTN) 
and isosorbide dinitrate (ISDN) during infusion using glass 
bottle/plastic infusion sets and glass syringe/infusion pumps. 
Drug 	Infusion Time Infusion Rate Per Cent Drug Recovered  
(hours) 	(ml/min) 	Plastic 	Glass 
Infusion Syringe 
Sets 	Infusion 
Pump 
GTN 8 0.07 28 95.2 
8 0.75 66 99.1 
ISDN 6 0.75 70.1 100 
Table 5.4. Loss of isosorbide dinitrate during infusions 
using different intravenous administration systems 
INFUSION SYSTEM 	INFUSION RATE PER CENT DRUG 
ml/min. 	RECOVERED 
Bag + Buretrol 	0.20 	63.3 
	
0.75 	70.1 
1.60 77.1 
Glass bottle + Buretrol 	0.78 	79.4 
1.60 81.4 
Glass bottle + Tubing 	0.73 	91.5 
infusion 	systems is plotted against time (results for 	the 
bag prepared 24hrs in advance are not included because more 
than 40mg of nitroglycerin was sorbed by the infusion bag 
before the infusion). 
Recoveries, expressed as percentages of original strength, 
of nitroglycerin in the bulk samples collected during some 
infusions are shown in Table 5.3. 
(b) Isosorbide Dinitrate 
The results of similar experiments involving the loss of 
isosorbide dinitrate 	from aqueous solutions are presented 
in Figure 5.19 and Tables 5.3 and 5.4. Recoveries of 
isosorbide dinitrate after simulated infusions were greater 
than recoveries of nitroglycerin for a comparable flow 
rate. 
5.3. KINETIC STUDIES WITH PLASTIC SHEETS AND TUBING 
5.3.1. Sorption 
The rate at which an organic nitrate was taken up by 
polyvinyl chloride was temperature dependent. However, the 
absolute amount of any one drug sorbed was the same for 
most temperatures (Figures 5.20 to 5.22). 
Ethylene glycol dinitrate and nitroglycerin reached an 
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equilibrium between water and cellulose propionate. 	After 
1 month isosorbide dinitrate had not reached an equilibrium 
between water and plastic. The profiles of uptake of these 
drugs are shown in Figure 5.23. 
5.3.2. Permeation 
The rates and extent of loss of nitroglycerin and ethylene 
glycol dinitrate from aqueous solutions in contact with 
polyvinyl chloride sheets at 45°C were greater in the 
diffusion cells in which the plastic sheets were not 
completely covered by metal (Figures 5.24 and 5.26). In 
cells where the plastic sheet was covered by metal, an 
equilibrium concentration of drug in solution was 
approached, however in those cells in which the plastic 
sheet was exposed to the air, 	a point was approached at 
which there was no drug left in solution. 	This effect 
occurred at a faster rate for ethylene glycol dinitrate at 
45°3 C than for nitroglycerin at 	5 ° C. 
There were no differences in the rate or extent of loss of 
isosorbide dinitrate from aqueous solutions in contact with 
polyvinyl chloride sheets at 45°C when these sheets were 
either covered by metal or left uncovered (Figure 5.25). 
5.3.3. Partition Coefficients 
Octanol-water, 	hexane-water, 	polyvinyl chloride-water, 
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Figure 5.20 Uptake with time of nitroglycerin (GTN) by polyvinyl chloride 
(PVC) strips immersed in drug solution (400 mcg/ml water) at 
• 4°C; 0 room temperature (20° - 24°C); A 37 ° C; 0 45°C; • 60°C. 
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Figure 5.21 Uptake with time of isosorbide dinitrate (ISDN) by polyvinyl chloride 
(PVC) strips immersed in drug solution (275 mcg/ml water) at 10 4°C; 
0 room temperature (20°C - 24°C); A 37°C; 0 45°C; I 60°C. 
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Figure 5.22 Uptake with time of ethylene glycol dinitrate (EGDN) by polyvinyl 
chloride (PVC) strips immersed in drug solution (500 mcg/ml water) 
at • 4°C; 0 room temperature (20°C - 24°C); A 37°C; 045°C; • 60°C. 
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Figure 5.23 Uptake with time of nitroglycerin (m), isosorbide dinitrate (•) 
and ethylene glycol dinitrate (A) by cellulose propionate (CP) 
strips immersed in drug solution (400 mcg/ml water) at room 
temperature. 
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Figure 5.24 Percentage of nitroglycerin (GTN) remaining in solutions stored 
in contact with covered (open symbols) or uncovered (closed 
symbols) polyvinyl chloride sheets using a diffusion •cell. 
o • room temperature (20°- 24°C); 0 • 45°C. 
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Figure 5.25 Percentage of isosorbide dinitrate,(ISDN) remaining in solutions stored 
in contact with covered (0) or uncovered (0) polyvinyl chloride 
sheets using a diffusion cell at 45°C. 
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Figure 5.26 Percentage of ethylene glycol dinitrate (EGDN) remaining in solutions 
stored in contact with covered (0) or uncovered (•) polyvinyl 
chloride sheets using a diffusion cell at 45°C. 
Table 5.5. Partition coefficients of nitroglycerin (GTN), 
isosorbide dinitrate (ISDN) and ethylene glycol dinitrate 
(EGDN) 
GTN ISDN EGDN 
Octanol/water 
Hexane/water 
Polyvinyl 
chloride/water 
Cellulose 
prOpionate/water 
High density 
polyethylene/water 
41.8 
2.1 
115.2 
1118 
0.3 
20.6 
1.4 
38.7 
<0.3 
14.6 
1.3 
31.2 
130 
<0.3 
cellulose 	propionate-water 	and 	high 	density 
polyet'hylene-water partition coefficients of the organic 
nitrates are presented in Table 5.5. The octanol-water and 
hexane-water partition coefficients of the organic nitrates 
are in the same rank order as the polyvinyl chloride-water 
and cellulose propionate-water partition coefficients. 
The polyvinyl chloride-water partition coefficients of the 
three drugs were not dependent on temperature (Figures 5.20 
to 5.22). 
5.4. PREVENTION OF LOSS 
5.4.1. Organic Nitrates 
When solutions of nitroglycerin were infused from glass 
syringes through high density polyethylene tubing, the 
extent of loss was greatly reduced when compared to plastic 
giving sets. The loss was flow rate dependent, however, 
even at the very slow flow rate of 0.07 ml/min the loss was 
only about 5% and at 0.75 ml/min the loss was only 0.9% 
(Table 5.3). 
No loss of isosorbide dinitrate occurred when infusing this 
drug from glass syringes through high density polyethylene 
tubing (Table 5.3). 
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5.4.2. Other Drugs 
loss of diazepam or chlormethiazole occurred when 
infusing these drugs from glass syringes through high 
density polyethylene tubing. 
58 
CHAPTER 6 
DISCUSSION 
6.1. ANALYTICAL METHODS 
The kinetic assay of Fung et al (1973) for nitroglycerin in 
aqueous solutions is also suitable for 	the analysis of 
erythritol tetranitrate, mannitol hexanitrate, 
pentaerythritol tetranitrate and other poly-nitric esters 
bearing more than two nitrate groups per molecule (Yap et 
al, 1975a). Isosorbide dinitrate and ethylene glycol 
dinitrate, having only two nitrate groups per molecule, are 
unsuitable for analysis by this method. For convenience, 
as well as to detect any breakdown products of the parent 
drugs, the HPLC method was used. 	This method was used to 
complete 	initial studies involving nitroglycerin, and when 
shown to be 	precise for the analysis of isosorbide 
dinitrate and ethylene .glycol 	dinitrate, was also used in 
studies involving interactions of those two drugs with 
plastic intravenous equipment. 
6.2. STORAGE STUDIES 
6.2.1. Formulation Factors 
Nitroglycerin for intravenous infusion has been formulated 
in normal saline (Kaplan et al, 1976) and in 5% dextrose in 
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water (Chiche et al, 	1979). 	The lack of effect of normal 
saline and 5% dextrose on the disappearance rate of 
nitroglycerin from aqueous solutions stored in plastic 
infusion bags (Figure 5.7) is consistent with the previous 
report of Sturek et al (1978). 
The 	concentrations 	of nitroglycerin 	and 	isosorbide 
dinitrate used for intravenous infusions vary considerably. 
Concentrations of 32 mcg/ml (Kaplan et al, 1976), 60 mcg/ml 
(Chiche et al, 1979), 100 mcg/ml (Christensson et al, 
1969), 120 and 240 mcg/ml (Hill et al, 1981) and 400 mcg/ml 
(Flaherty et al, 1975) have been used in nitroglycerin 
infusions, 	while 	for 	isosorbide dinitrate infusions, 
concentrations of 50 mcg/ml 	(Taylor ' et 	al, 1980) and 200 
mcg/ml (Distante et al, 1979) have been used. 
In the current work the fraction of nitroglycerin and 
isosorbide dinitrate, as well as ethylene glycol dinitrate, 
sorbed from solution by the infusion bags has been shown to 
be independent of the concentration of drugs used (Figures 
5.7 to 5.9).. The fractions of vitamin A and methohexital 
sorbed from solutions by Viaflex plastic infusion bags also 
appear to be independent of concentration, whereas for 
warfarin, the fraction sorbed decreases with increasing 
warfarin concentrations 	(Moorhatch & Chiou, 1974a). 	In a 
recent publication, Parker et al (1979) 	reported 	that the 
percentage loss of diazepam from infusion bags was a 
function of concentration. 	Their results could also be 
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explained, in part, by differences in the surface areas of 
plastic per unit volume of solution for the two 
concentrations used. 
The volume of nitroglycerin solution in a plastic infusion 
bag has been shown to influence the fractional loss of 
nitroglycerin from solution (Figure 5.12a). As the volume 
of the nitroglycerin solution in the plastic infusion bag 
decreases during infusions, the fraction of drug sorbed 
increases because the surface area of plastic to volume of 
solution ratio increases •as the volume of solution in the 
bag is decreased (e.g. during nitroglycerin infusion) due 
to the "collapsing" of the bag. Thus, the concentration of 
nitroglycerin in the smaller volumes decreases to a greater 
extent with time than for the larger volumes. This means 
that towards the end of an infusion, the fractional loss of 
nitroglycerin is relatively higher than at the beginning 
because not only is drug still being lost to the burette 
and tubing of the giving set, but a greater rate of loss of 
drug to the bag is occurring. 
Polack et 	al 	(1970) 	and 	Roberts et al (1979) have also 
shown that the disappearance of some solutes from plastic 
containers during storage is a function of the surface area 
of plastic per unit volume of solution. 
For all volumes of solution stored in the burette, 	the 
surface area of plastic per unit volume of solution is 
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constant when the contribution of the base of the burette 
(a high density plastic) 	to the 	total 	surface area is 
neglected. Conse0ently, the fraction of nitroglycerin 
remaining in aqueous solutions stored in the burettes for 
various times appears to be independent of the volume of 
solution in the burette (Figure 5.12b). - 
It has been suggested by Fung 	(1978) 	and McNiff et al 
(1979) 	that some discrepancies have appeared 	in 	the 
literature 	concerning 	the stability of nitroglycerin 
solutions for intravenous use. 	In 	the present work, the 
loss of nitroglycerin from aqueous solutions stored 	in 
glass containers (with metal 	screw caps) 	over 96hrs was 
minimal 	(<1%), consistent with the observations of McNiff 
et al (1979) 	and 	Baaske et al (1980). 	Indeed, even after 
storage for up to 1000hrs, 	there was only minimal loss of 
nitroglycerin 	(<2%) 	and this was probably 	due 	to 
hydrolysis. 	Other studies 	(Sturek et 	al, 1978; Ludwig & 
Ueda, 	1978) 	showed some loss of nitroglycerin stored 	in 
glass containers. In the study of Ludwig & Ueda (1978), 
loss probably arose from interaction of nitroglycerin with 
the rubber/plastic components (e.g. bung, administration 
set) of the bottles which were used. 
6.2.2. Temperature 
At the elevated 	temperatures of accelerated stability 
testing, nitroglycerin, 	isosorbide dinitrate and ethylene 
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glycol dinitrate were rapidly lost from their aqueous 
solutions when stored in polyvinyl chloride infusion bags 
(Figures 	5.13 to 5.15). 	For nitroglycerin and isosorbide 
dinitrate, 	the clinically used drugs, loss was very much 
slower 	at 4,°:;C than at room temperature or above. 	This 
temperature-dependent loss of nitroglycerin has also been 
reported by McNiff et al (1979) 	and 	Baaske 	et al (1980). 
Although less than 10% of the original concentration of 
these two drugs is lost during storage in infusion bags for 
24hrs at the temperature of the solution has to be 
increased to about room temperature before infusions can be 
given. 	At this higher temperature significant amounts of 
nitroglycerin 	and isosorbide dinitrate are lost from 
solution. 	Thus, keeping the bags at 4C only temporarily 
reduces the problem of loss due to sorption. 
At elevated temperatures, hydrolysis 	of 	the organic 
nitrates appeared to play no part in the loss of these 
drugs. High-pressure liquid chromatographs did not show 
the presence of any lower esters of any of the three 
organic nitrates tested. This is consistent with 
literature reports on the hydrolysis of ethylene glycol 
dinitrate in aqueous solution at 60?,C (Urbanski, 1965). 
Over the time of the experiments using plastic bags at 60 ° C 
(1000 hours), 0.067% of the ethylene glycol dinitrate would 
have been expected to be hydrolyzed according to the 
figures of Urbanski (1965). The same author presents data 
to suggest that hydrolysis of nitroglycerin in aqueous 
6 3 
solution at 60 3 C proceeds at a rate much slower than that 
for ethylene glycol dinitrate. 
6.2.3. Light 
The finding that room light had no effect on the loss of 
nitroglycerin from solutions stored in plastic bags has 
also been reported by Sturek et al (1978) and Ludwig and 
Ueda (1978). 
6.3. DYNAMICS OF ORGANIC NITRATE - PLASTIC INTERACTION 
6.3.1. Sorption and Permeation 
The polyvinyl chloride-water partition coefficient obtained 
for 	nitroglyderin is consistent with 	that 	reported 
previously by Yuen et al (1979). These workers also found 
that the partition coefficient is independent of initial 
concentration of drug in solution. In the current work, 
the polyvinyl chloride-water partition coefficients (K) 
calculated from sorption studies are in the rank order 
K(GTN) > K(ISDN) > K(EGDN) and this parallels both the 
octanol-water 	partition 	coefficients and hexane-water 
partition coefficients for these drugs (Table 5.5). Other 
workers have found a similar rank order of the cottonseed 
oil-water and corn oil-water partition coefficients for 
nitroglycerin and isosorbide dinitrate (Table 6.1). The 
cottonseed 	oil-water 	partition 	coefficients 	for 
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Table 6.1. Partition Coefficients of Nitroglycerin (GTN) 
and Isosorbide Dinitrate (ISDN) 
Partition Coefficient  
Drug 	Octanol- Hexane- 	Cottonseed Corn oil- PVC- 
water 	water 	oil-water water 	water 
GTN 41.8 	2.1 115.2 
ISDN 	20.6 	1.4 	41a 28b 
	
38.7 
(a) Needleman and Johnson (1975). 
(b) Levy (1970). 
Table 6.2. 	Half-times 
polyvinyl chloride sheets. 
4 	22 
for sorption of organic 
Half-time (hours) 
Temperature (°C) 
nitrates by 
Activation 
energy 
(Kcal/mole) 
60 	S.D. 30 37 45 
Nitroglycerin 
Isosorbide 
dinitrate 
Ethylene 
glycol 
dinitrate 
61 
100 
130 
13 
14 
16 
3.2a 2 
6.5 
8.5 
1.2 
4 
4.5 
1 
2 
2.5 
13.9 
'.12.1 
12.3 
± 0.31 
± 0.75 
± 0.16 
(a) Yuen et al (1979). 
nitroglycerin 	and 	isosorbide dinitrate determined by 
Needleman and Johnson (1975) are in very close agreement 
with the polyvinyl chloride-water partition coefficients 
found in the current work (Table 6.1). 
No attempt was made to evaluate the reasons for the 
differences in the cottonseed oil-water, polyvinyl 
chloride-water, octanol-water and hexane-water partition 
coefficients because of the different natures of the binary 
systems in relation to hydrogen bonding and water content 
of the solvents. Polyvinyl chloride contains 
anti-oxidants, plasticizers and preservatives (Autian, 
1971) and cottonseed oil contains membrane fragments with 
many -NH and -OH groups (Leo et al, 1971), all of which 
could play a role in the binding of the organic nitrates. 
Studies 	of the sorption of the organic nitrates by 
cellulose propionate sheets showed that only ethylene 
glycol dinitrate and nitroglycerin reached equilibrium 
between water and plastic after 1 month (Figure 5.23). The 
larger plastic-water partition coefficients for the drugs 
associated with cellulose propionate compared to polyvinyl 
chloride (Table 5.4) are due to the differences in the 
nature of the plastics. The slower rate of uptake of 
isosorbide dinitrate compared to ethylene glycol dinitrate 
and nitroglycerin is probably due to the drug diffusing 
more slowly through the cellulose propionate. The large 
plastic-water 	partition 	coefficients 	associated with 
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cellulose propionate reflect the more rapid rate of loss of 
ethylene glycol dinitrate and nitroglycerin from solutions 
stored in intact burettes of giving sets than from 
solutions stored in intact polyvinyl chloride infusion 
bags. 
Permeation studies at 45 ° C showed that nitroglycerin and 
ethylene glycol dinitrate are lost to the environment. 
However, there was no apparent loss of nitroglycerin to the 
environment when the experiments were performed at room 
temperature (some loss may possibly become apparent over 
much longer storage times) (Figures 5.24 to 5.26). This 
increased loss at higher temperatures is probably due to an 
increase in the vapour pressure of nitroglycerin and 
ethylene glycol dinitrate when the ambient temperature is 
raised from 20°C to 45°C (a twenty fold increase for 
nitroglycerin and a ten fold increase for ethylene glycol 
dinitrate) (Urbanski, 1965). It is unlikely that these 
differences result from chemical decomposition of the drugs 
in the plastic. Decomposition of the organic nitrates in 
the plastic would be expected to be the same in sheets 
exposed to the environment and in sheets protected by a 
metal "barrier". 
Isosorbide dinitrate was lost from solution at the same 
rate and to the same extent for both covered and uncovered 
plastic sheets (Figure 5.25). Although no information 
about the vapour pressure of isosorbide dinitrate is 
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available in the literature, it is significant at room 
temperature (C. Fitzmaurice, personal communication) due to 
the semi-polar bond of its nitro groups, a characteristic 
of the other organic nitrates (Urbanski, 1965). If it has 
a lower vapour pressure than nitroglycerin then the reduced 
loss of isosorbide dinitrate at elevated temperatures 
compared to the other organic nitrates under investigation 
is consistent with the results obtained. 
6.3.2. Models 
It was not the purpose of the current work to evaluate 
different mathematical 	models 	with 	regard to their 
applicability in describing the loss of organic nitrates 
from aqueous solutions stored 	in or being infused through 
plastic intravenous infusion equipment. 	However, work in 
this laboratory has shown that the results obtained for the 
loss of nitroglycerin from solutions stored in polyvinyl 
chloride infusion bags were better described by a diffusion 
model (Section 2.1.2. (b)), than by a two compartment model 
(Section 2.1.2. (a)). 
Yuen et al 	(1979) 	also obtained 	good agreement between 
their actual results and predictions based on a diffusion 
model when examining the uptake of nitroglycerin from 
aqueous solution by polyvinyl chloride strips immersed in 
drug solution. These workers presented • results which 
showed that the time for 50% sorption of nitroglycerin at 
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30°C was 3.2 hours. 	This time is compared to times for 50% 
sorption of nitroglycerin obtained from sorption studies in 
the current work at various temperatures in Table 6.2. 	It 
can be seen that 	the results of Yuen et al (1979) •are 
consistent with results for the current work. 	Half-times 
for sorption of isosorbide dinitrate and ethylene glycol 
dinitrate are included in Table 6.2. These two organic 
nitrates appear to diffuse in the plastic more slowly than 
nitroglycerin probably as a result of subtle differences in 
their molecular structures. 
The activation energies for diffusion for the three organic 
nitrates determined from the Arrhenius relationship were 
found not to be statistically significantly different. 
Autian (1971) suggested that the activation energy for 
diffusion of solutes in plastics corresponds to (1) the 
energy needed to move polymer chains sufficiently apart to 
create a "hole" and (2) the energy needed to move the 
diffusing molecule into the "hole". As the activation 
energies for the three organic nitrates are similar, it is 
unlikely that the nature of interaction of individual 
molecules with the plastic is determining the observed 
activation energies. Instead, the activation energies 
probably result from changes in the mobility of the polymer 
chains (in the polyvinyl chloride film) with temperature. 
Yuen 	et 	al 	(1979) 	suggested 	that 	absorption of 
nitroglycerin was the major source of loss of drug, however 
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they could not discount the possibility of adsorption of 
the drug on the surface of the plastic. 	Consequently 
Sokoloski et al (1980) showed that a first-order adsorptive 
process was responsible for a rapid 	initial loss of 
nitroglycerin on polyvinyl chloride. 	The data of these 
workers conformed to Polanyi adsorption potential theory 
which has been described by Schenz and Manes (1975). 
All of the above work was, however, performed using 
isolated polyvinyl chloride sheets fully immersed in 
aqueous drug solution. From the experimental data in the 
current work showing that loss of nitroglycerin from 
solutions stored in intact plastic bags still occurs after 
1000hrs and that vaporization of nitroglycerin could play a 
part in the loss of this drug from aqueous solutions stored 
in intact polyvinyl chloride infusion bags, a combination 
of the Polanyi and diffusion models may still not 
accurately describe the loss of nitroglycerin. 
6.4. SIMULATED INFUSIONS 
6.4.1. Infusions Simulating Clinical Studies 
(a) Nitroglycerin 
The rate of infusion of nitroglycerin to patients suffering 
acute myocardial infarction generally starts at about 10-20 
mcg/min and is then increased in increments of 10-20 
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mcg/min until a desired haemodynamic 	(fall in systemic 
pressure) 	or clinical 	(relief of chest pain) 	response 
occurs. 	Depending on the initial 	concentration 	of 
nitroglycerin in the 	infusion bag, 	initial flow rates 
associated with these doses have been in the range of about 
0.04•ml/min (Hill et al, 1981) to 0.3 ml/min (Flaherty 	et 
al, 1975) 	with 	final 	infusion 	rates 	in the range of 2 
ml/min 	(Hill 	et 	al, 1981) to 5 ml/min (Flaherty et 	al, 
1975). Thus, as the loss of nitroglycerin during simulated 
infusions is flow rate dependent (Figure 5.16), the extent 
of loss actually occurring in the clinical situation will 
vary widely. 
Results 	verifying the flow rate dependent 	loss 	of 
nitroglycerin 	(Figure 5.16) have recently been provided by 
Baaske et al (1980) 	and 	Christiansen et al (1980). 	The 
former workers also studied the loss of nitroglycerin 
associated with a flow rate of 2 ml/min and 	showed that 
about 30% of the original nitroglycerin 	is lost during a 
4hr infusion. These workers not only used Buretrol giving 
sets in their study but also seven other commercially 
available sets. All sets tested produced similar results. 
(b) Isosorbide Dinitrate 
The loss of isosorbide dinitrate during infusion through 
plastic giving sets is also flow rate dependent (Figure 
5.19). The extent of loss for any comparable flow rate is, 
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however, much less than observed 	for nitroglycerin. 	The 
extent of loss may be important in clinical studies in 
which isosorbide dinitrate has been infused. Distante et 
al (1979) infused isosorbide dinitrate during the treatment 
of angina at rest and claimed that this treatment was 
effective. If these workers used plastic infusion 
equipment to infuse isosorbide dinitrate, then some logs of 
the drug would probably have occurred. 	The rate of 
infusion of 0.1-0.3 ml/Min used by Distante et al 	(1979) 
resulted, in the present study, in a recovery of only 63% 
when infused from a plastic bag through a plastic giving 
set and a recovery of only 70% when infused at a rate of 
0.75 ml/min. 
6.4.2. Infusion Tubing Effluent Concentration-Time Profiles 
(a) Nitroglycerin 
Greatest 	loss 	(i.e. 	smallest 	concentrations 	of 
nitroglycerin in the effluent) are observed for the slowest 
flow rates where the contact time of a given volume of 
solution with plastic is greatest. The times for the 
minimum concentrations of nitroglycerin in the effluent 
reflect the time required for the solution in the tubing at 
the beginning of the infusion • to pass through the tubing. 
Subsequent solution entering the tubing from the glass 
infusion bottle will have a higher concentration of 
nitroglycerin in its effluent due to significant sorption 
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of nitroglycerin from the initial solution by the tubing. 
Since the tubing contains approximately 8m1 of solution, 
times of about 10, 15 and 35min would be anticipated for 
flow rates of 0.75, 0.52 and 0.23 ml/min respectively. The 
observed times for minimum concentrations of nitroglycerin 
in the effluent (Figure 5.17a) are of similar magnitude to 
these values for corresponding flow rates. For all flow 
rates, the concentration of nitroglycerin in the effluent 
eventually returns to the original concentration of 
nitroglycerin 	in the infusion bottle (Figure 5.17a). 	Loss 
of nitroglycerin during these infusions therefore arises 
solely 	from sorption by the plastic 	tubing. 	If 
decomposition, adsorption to the glass infusion bottle or 
loss to the external (atmosphere) environment had occurred, 
the concentration of nitroglycerin in the effluent for long 
times (i.e. steady—state) would not approach the original 
nitroglycerin concentration in the glass infusion bottles. 
Consistent with an equilibrium sorption process, the total 
cumulative amount of nitroglycerin sorbed by the plastic 
infusion tubing is independent of flow rate (Figure 5.17b). 
Since the sorption of nitroglycerin by the plastic infusion 
tubing is an equilibrium process, 	accurate delivery of 
known amounts 	of nitroglycerin to the patient could 
theoretically be achieved by pretreating the tubing before 
an infusion. For instance, the tubing could be flushed 
with solution from the attached glass infusion bottle at a 
rapid rate until the nitroglycerin concentration in the 
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effluent 	approached 	the 	original 	nitroglycerin 
concentration in the bottle. It can be calculated from the 
data in Figure 5.17 that approximately 350 to 400m1 of 
solution containing nitroglycerin should be flushed through 
the tubing over several hours to adequately pretreat the 
tubing before an infusion of nitroglycerin. 
(b) Isosorbide Dinitrate 
When isosorbide dinitrate solutions were infused from glass 
infusion bottles through plastic infusion tubing at 0.73 
ml/min it was about 4hrs before the effluent concentration 
of is6sorbide dinitrate approached the initial 
concentration (Figure 5.19c). The loss of isosorbide 
dinitrate at this flow rate is less than the loss of 
nitroglycerin solution infused through tubing at a similar 
flow rate (Figure 5.17). A reduced loss of isosorbide 
dinitrate is consistent with this drug's lower affinity for 
the polyvinyl chloride tubing as reflected by polyvinyl 
chloride-water partition coefficients (Table 5.5). 
6.4.3. Role of Infusion Set Components 
(a) Nitroglycerin 
Adding 	the 	plastic 	infusion b-ag 	(Viaflex) 	and burette 
(Buretrol) to the infusion tubing reduces the concentration 
of nitroglycerin appearing in the effluent of the tubing 
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(Figure 5.18a). 	The corresponding amount sorbed by the 
plastic infusion system (Figure 5.18b) for various times of 
infusion is increased by the addition of these components. 
During the initial stages of infusion, the concentration of 
nitroglycerin in the effluent dimipishes primarily as a 
result of sorption by the infusion tubing. At longer 
times, sorption of nitroglycerin by the plastic burette and 
infusion bag becomes more significant (Figure 5.18), 
consistent with the slower process of sorption by the 
burette and infusion bag compared to the infusion tubing. 
The apparent steady-state concentration of nitroglycerin in 
the effluent is less than the original nitroglycerin 
concentration in the plastic 	infusion bag/glass infusion 
bottle as a result of the additional 	sorption by the 
infusion bag and the burette. 
(b) Isosorbide Dinitrate 
When the plastic infusion bag and burette were added to the 
infusion tubing, the concentration of isosorbide dinitrate 
in the effluent of the tubing was decreased (Figure 5.19). 
The greater loss associated with using a giving set to 
infuse isosorbide dinitrate is due to the drug being lost 
relatively rapidly when its solutions are stored in the 
cellulose propionate burettes of the giving sets (Figure 
5.10). When using a plastic bag/giving set system the loss 
is even greater due to the sorption by the plastic bag 
(Figure 5.19a). 
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6.4.4. Other Drugs 
(a) Diazepam 
Literature reports about the possible flow rate dependent 
loss of diazepam when infusing this drug through plastic 
giving sets have been conflicting. There was no difference 
in the. concentration of diazepam in the 'effluent of the 
giving set tubing when diazepam was infused at flow rates 
of 24 and 48 ml/hr in one report (Parker and MacCara, 1980) 
however, profiles of drug loss with time were markedly 
different when diazepam solutions were infused at rates of 
5 ml/hr (MacKichan et al, 1980) and 100 ml/hr (Dasta et al, 
1980). The recovery of diazepam after the slower infusion 
(MacKichan et al, 1980) was about 9%, compared to a 
recovery of about 64% after an infusion at 100 ml/hr for 5 
hours (Dasta et al, 1980). 
These results suggest that the loss of diazepam when 
infused through plastic giving sets is, in part, flow rate 
dependent just as the losses of nitroglycerin and 
isosorbide dinitrate are in part due to the flow rate of 
drug solution through the giving set. 
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(b) Chlormethiazole 
Tsuei et al (1980) reported a flow rate-related 	loss of 
chlormethiazole in simulated infusions using plastic giving 
sets. They found that the greatest loss of chlormethiazole 
occurred when its solutions were allowed to stand in the 
giving sets and this loss was progressively reduced as the 
flow rate was increased from 75 ml/hr up to 999 ml/hr. 
6.5. THERAPEUTIC AND PHARMACOKINETIC IMPLICATIONS 
6.5.1. Therapeutics 
The 	clinically 	relevant 	consequence of drug-plastic 
interactions involving sorption is that the amount of drug 
being delivered to the patient is lower than anticipated. 
For drugs which are used in acute stages of coronary 
disease it is important that the amount 	of a drug 
administered is sufficient and quantified. 	Although it is 
still unclear what dose of nitroglycerin 	is needed to 
minimize 	the 	extent 	and 	severity of a myocardial 
infarction, it has been clearly shown 	(Chiche et al, 1979; 
Epstein et al, 1975) that nitroglycerin 	infusion reduces 
electrocardiographic signs of extension of necrosis and 
mortality when associated with left ventricular failure 
during myocardial infarction. 
When 	nitroglycerin 	is 	administered 	intravenously, 
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clinicians may use haemodynamic signs, such as reduction in 
blood pressure or increase in pulse rate, to determine the 
efficacy of this dosage route. With a fast-acting drug 
like nitroglycerin it may therefore be possible to titrate 
the patient to a pharmacological endpoint without the need 
to know exactly how much drug is being infused. 	This 
titration technique may not always be successful. 	The 
current work was initiated when patients suffering acute 
myocardial infarction at the Royal Hobart Hospital failed 
to register pharmacological endpoints, as measured by 
changes in some haemodynamic parameters, during infusions 
of nitroglycerin of amounts supposedly up to 300 mcg/min. 
Thus this titration technique may not always be successful. 
6.5.2. Pharmacokinetics 
Some 	workers 	have reported the pharmacokinetics 	of 
isosorbide dinitrate 	after oral 	and 	sublingual doses 
(Assinder et al, 1977; Sporl—Radun et al, 1980) but the 
pharmacokinetics of isosorbide dinitrate after intravenous 
administration has been published only recently (Taylor et 
al, 1980). It is essential in clinical pharmacokinetic 
studies to have an accurate measure of the rate of infusion 
of a drug. If a plastic bag/giving set system is used to 
infuse isosorbide dinitrate, blood clearance could be 
over—estimated by as much as 40% and systemic availability 
similarly under—estimated. In 	the 	report on the 
pharmacokinetics of isosorbide dinitrate after intravenous 
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infusion 	(Taylor et al, 1980) an "infusion set" was used. 
The nature of the infusion system used by these workers is 
unclear. If the plastic bag/giving set system described in 
the current work had been used at an infusion rate employed 
in the pharmacokinetic evaluation (Taylor et al, 1980) i.e. 
1.6 ml/min, a loss of about 20% of initial drug 
concentration would have occurred as a result of sorption 
of isosorbide dinitrate by the intravenous administration 
system. Consequently, systemic availability and volume of 
distr'ibution 	would s be 	under-estimated and clearance 
over-estimated by about 20% respectively. 
The detailed pharmacokinetics 	of 	nitroglycerin after 
intravenous infusion have not yet been described. 	However, 
Wei and 	Reid (1979) measured plasma levels of the drug 
after a slow intravenous infusion. 	It is not clear what 
type of intravenous infusion equipment these workers used. 
In that study there was no correlation between the rate of 
nitroglycerin infusion and the plasma nitroglycerin 
concentration. This may have been due to the rapid rate of 
metabolism of nitroglycerin in the patients or to the 
reduced availability of nitroglycerin if plastic infusion 
equipment was used. 
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6.6. PREVENTION OF LOSS 
6.6.1. Organic Nitrates 
Losses of nitroglycerin were minimized when solutions of 
the drug were infused from a glass syringe via a short 
piece of high density polyethylene tubing. The loss using 
this system ranged from less than 1% to less than 5% for 
infusion rates of 0.75 ml/min and 0.07 ml/min respectively 
(Table 5.3). This reduced loss when compared to the losses 
recorded when polyvinyl chloride infusion equipment is used 
is consistent with the very much smaller affinity of 
nitroglycerin for high density polyethylene as expressed by 
the plastic-water partition coefficients (Table 5.5). 
Mathot et al (1980) have shown that as well as high density 
polyethylene, teflon and polypropylene can be used to 
infuse nitroglycerin without loss of the drug. They 
observed no loss of nitroglycerin when aqueous solutions of 
it were infused from a polypropylene syringe through 
polyethylene tubing. 
Amann et al 	(1980) 	used 	a polyolefin bottle to prepare 
nitroglycerin solutions and found 	that 	after 	48hrs 
nitroglycerin potencies remained within 6.5% of their 
initial values. 	If these bottles were to be used for 
nitroglycerin infusions, 	the large loss of nitroglycerin 
which occurs during transit of the drug solution through 
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Table 6.3. Recoveries of Diazepam and Chlormethiazole during 
infusions using glass bottle/plastic infusion sets and glass 
syringe/infusion pumps. 
Drug 	Infusion Time Infusion Rate Per Cent Drug Recovered  
. (Hours) 	(ml/min) 	Plastic 	Glass 
Infusion Syringe 
Sets 	Infusion 
Pump 
Diazepam 24 0.08 	9.1a 100 
Chlormethiazole 5 1.1 	782b 100 
aMacKichan et al (1979) (estimated from area under curve) 
bTsuei et al (1980). 
plastic giving sets would still have to be overcome. 
Isosorbide dinitrate is not lost when its aqueous solutions 
are infused 	from glass syringes through high density 
polyethylene- tubing (Table 5.3). This finding is in 
accordance with the almost negligible partitioning of 
isosorbide dinitrate between water and high density 
polyethylene (Table 5.5). 
6.6.2. Other Drugs 
The glass syringe-high density polyethylene tubing infusion 
system also prevents the previously reported loss of 
chlormethiazole (Tsuei et al, 1980) and diazepam (MacKichan 
et al, 1979) when used at comparable infusion rates to 
those used in their studies, during infusion of these drugs 
through plastic giving sets (Table 6.3). 
6.7. FUTURE WORK 
The results presented in the current work show that 
patients receiving intravenous infusions of nitroglycerin 
or 	isosorbide dinitrate via plastic intravenous infusion 
equipment could receive only a small 	fraction of the 
intended doses. 	This example shows that a drug-plastic 
interaction has created the potential 	for therapy to fail. 
Other drugs need to be evaluated in terms of their ability 
to be sorbed by any plastic container with which they come 
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into contact. Moreover, new plastic containers should be 
evaluated 	for possible leaching of toxic substances from 
them into drug solutions. 	These areas of investigation are 
relatively more important for drugs and plastics associated 
with parenteral therapy. Recently Kowaluk et al (1981) 
surveyed a large number of drugs currently administered 
parenterally in order to detect drugs which are liable to 
be affected by drug-plastic interactions and this sort of 
survey may have to be done periodically to evaluate 
possible interactions between new drugs and their plastic 
delivery systems. 
Further 	work 	on 	the most 	appropriate 	models 	to 
mathematically describe the loss of solutes from solutions 
stored in plastic containers is required if the dynamics of 
drug-plastic interactions are to be better understood. The 
processes which control the disappearance of solutes have 
not been fully described and so work in this area could 
proceed with a view to gaining some predictive index of 
interaction. 
Evaluation of the compatibility of existing drugs with 
plastic delivery systems and 	the ability to predict such 
interactions for new drugs should 	minimize potential 
drug-plastic interactions and possible therapeutic 	failure 
resulting from those interactions. 
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